hg_187900.1

Basic information about the TSS

---

TSS ID: hg_187900.1 Species: human Chr: chr20		Start: 50931056 End: 50931074 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AF250860 Distance: 67 GeneID: 23394 HGNC/MGI_ID: HGNC:15766 UniProt_ID:

Gene_name: activity dependent neuroprotector homeobox Gene_symbol: ADNP Gene_synonyms: ADNP1 KIAA0784 Gene_source: HGNC:15766

TATA-Box annotation

---

Distance to TSS:	81
Nearest PromoterID:	NR_110009
Entrez ID:	101927631
Nearest Unigene:	Hs.301898
Nearest Refseq:	NR_110007
Nearest Ensembl:	ENSG00000259456
Gene Name:	activity dependent neuroprotector homeobox
Gene Alias:	-
Gene Description:	ADNP antisense RNA 1
Gene Type:	ncRNA
CpG%:	0.18
GC%:	0.80597
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ADNP p2@ADNP p3@ADNP p4@ADNP p5@ADNP p6@ADNP p7@ADNP p8@ADNP
Sample		p1@ADNP	p2@ADNP	p3@ADNP	p4@ADNP	p5@ADNP	p6@ADNP	p7@ADNP	p8@ADNP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	38.96	12.27	1.56	2.14	1.17	0.39	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	37.83	12.14	2.63	3.03	1.62	0.00	0.61	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.55	13.70	1.74	2.70	1.74	0.96	1.16	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.11	15.59	1.46	2.08	0.42	0.21	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.54	11.02	1.80	2.25	0.45	0.90	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.53	13.18	2.52	1.74	0.97	0.78	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	34.21	16.78	3.49	3.27	2.40	0.65	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	35.36	16.23	1.45	3.39	1.94	0.24	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.99	14.11	2.35	3.42	0.43	0.00	0.64	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	51.59	45.79	9.27	4.64	0.58	1.74	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	50.93	36.79	3.23	5.66	0.40	0.40	0.81	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	55.29	36.18	4.47	6.91	2.85	0.41	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	50.61	2.74	1.13	0.81	0.64	0.16	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	41.80	2.10	0.45	0.75	0.00	0.15	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	43.25	1.76	0.22	1.32	1.54	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	37.22	2.01	1.01	0.00	2.26	0.25	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.23	1.31	0.44	1.53	1.09	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.34	3.37	1.27	1.27	0.84	1.27	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	32.52	3.20	0.53	0.00	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	42.42	1.81	0.45	1.20	0.45	0.15	0.15	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.57	1.60	1.07	0.67	1.74	0.13	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.15	1.55	0.69	0.69	0.35	0.35	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	38.65	3.10	0.78	1.16	0.78	0.65	0.13	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	36.16	2.18	0.97	0.49	0.49	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	35.34	2.58	1.03	1.29	0.77	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.45	2.85	2.85	0.32	0.63	0.63	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	37.36	2.75	1.65	0.00	0.55	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	49.04	4.48	1.41	2.12	0.94	0.24	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.77	2.10	0.65	0.97	1.13	0.16	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	34.38	3.44	0.54	0.72	1.09	0.18	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	33.08	1.88	0.42	0.21	0.84	0.42	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	30.48	1.95	1.37	0.78	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.76	4.01	0.63	0.84	1.69	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	29.03	2.31	0.99	1.15	0.99	0.16	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.41	2.24	0.56	0.56	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	38.13	3.64	1.34	2.11	0.38	0.38	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	32.91	2.66	1.43	0.82	0.82	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.63	3.63	0.60	1.01	0.81	0.20	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.63	4.32	0.54	0.81	0.27	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	27.61	2.16	0.72	0.72	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.05	3.29	1.18	2.12	0.71	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.86	1.90	0.88	1.32	1.02	0.00	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.89	2.95	1.05	1.48	0.84	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	35.14	3.67	0.70	0.52	0.52	0.17	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.54	3.61	0.80	1.00	0.60	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	33.27	4.42	2.56	2.56	0.93	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	30.47	3.12	0.72	0.48	1.20	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.79	5.36	1.19	0.60	0.60	0.00	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	26.57	4.31	1.20	1.91	0.48	0.24	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	28.91	4.04	0.81	1.42	1.01	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.87	3.07	0.82	0.82	1.23	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.13	6.00	0.67	0.89	0.44	0.67	0.44	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.03	4.61	0.71	1.06	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.25	4.31	0.33	1.33	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	63.76	7.55	2.52	1.68	1.68	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.34	2.76	0.46	1.84	0.46	0.00	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.64	5.51	0.65	0.32	0.97	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.02	4.18	1.93	0.64	0.64	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.26	3.14	1.26	1.57	0.31	0.00	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.15	4.94	1.41	0.00	0.00	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.26	1.68	0.56	2.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	63.69	6.37	1.59	1.59	2.39	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.63	6.46	0.00	1.70	0.68	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.85	3.90	0.65	0.97	0.65	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	10.65	4.61	1.06	1.06	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	3.90	0.49	0.98	0.49	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.95	2.48	0.00	0.50	0.50	0.99	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	4.22	0.00	0.00	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	12.92	2.98	0.66	0.99	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	4.33	0.93	1.55	0.00	0.00	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	4.28	1.53	0.61	0.31	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	11.88	0.95	0.79	0.63	0.16	0.00	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	20.53	1.12	0.32	0.80	0.80	0.32	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	15.27	1.40	0.38	0.76	0.64	0.51	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	10.46	2.24	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	15.41	2.68	0.33	0.00	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	8.29	2.55	0.00	0.00	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	1.35	1.81	0.90	0.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.98	0.70	0.35	0.35	0.87	0.35	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	44.79	3.52	1.96	1.37	0.59	0.39	0.20	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	28.83	3.35	1.54	1.03	1.03	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	34.85	2.79	4.18	1.39	1.39	0.56	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	41.15	4.11	3.53	2.35	1.76	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	41.99	3.54	2.09	1.85	1.85	0.64	0.24	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	30.66	3.55	1.94	2.58	1.94	0.00	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	34.66	1.60	1.07	0.53	0.53	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	33.39	2.23	1.11	0.56	2.78	0.00	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	22.46	1.25	0.42	0.00	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	27.38	2.01	0.75	1.26	0.00	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	27.82	1.96	1.31	0.65	0.33	0.33	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	25.58	1.83	1.22	0.91	0.30	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	12.38	2.21	0.88	1.10	0.66	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	6.10	1.08	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.27	1.98	2.52	0.72	1.08	0.18	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	1.67	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	20.34	2.47	1.64	0.21	1.23	0.41	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	25.86	2.63	0.80	0.80	1.03	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	25.72	0.73	0.49	0.73	0.98	0.98	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.58	0.45	1.35	0.00	0.00	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.33	0.43	1.74	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.05	0.90	2.09	0.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	0.00	2.53	0.00	0.00	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	1.32	1.98	0.00	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	2.27	0.97	0.97	0.65	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	1.46	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	3.56	1.19	0.59	0.59	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	1.13	3.39	0.38	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	0.73	1.45	1.45	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.07	1.32	1.15	0.99	0.49	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.18	0.75	0.30	0.45	0.15	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.57	1.07	1.61	1.07	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.98	2.27	0.76	0.57	0.00	0.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.09	1.60	0.80	0.80	0.27	0.53	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	2.93	0.98	0.98	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.11	1.33	1.00	0.66	0.33	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	3.60	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.21	1.54	1.54	0.86	0.17	0.86	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	0.97	2.91	0.49	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.56	1.52	1.90	0.38	1.14	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	1.21	1.21	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.83	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.05	1.71	1.71	0.43	0.21	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.97	1.03	1.81	0.52	0.52	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	1.41	0.00	0.00	0.94	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.90	1.93	0.32	0.96	0.64	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	0.71	0.71	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.04	0.58	1.17	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.54	1.20	2.71	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.15	1.53	1.02	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.70	1.53	1.27	0.76	0.25	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	1.27	1.91	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	2.16	0.00	0.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.70	1.27	0.85	0.64	0.64	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.90	0.29	1.45	0.00	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	0.00	1.89	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.04	2.03	1.02	1.36	0.00	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	2.11	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.51	1.29	1.07	0.00	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	0.60	1.80	0.00	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.72	1.84	1.61	0.69	0.00	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	2.55	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.58	0.76	1.02	0.00	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.77	2.06	1.24	1.03	0.62	0.62	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	1.53	0.00	0.31	0.31	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	11.95	0.96	1.91	0.00	0.48	0.48	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.98	1.55	2.00	0.67	0.00	0.44	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	0.55	1.66	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.92	1.32	0.26	0.79	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	2.54	0.36	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	26.53	4.79	2.46	0.98	0.74	0.74	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	27.56	5.13	0.86	1.03	1.03	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	17.62	2.10	0.42	0.63	0.42	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	35.90	5.58	1.74	3.83	1.74	0.35	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	43.84	8.57	4.53	3.56	2.43	1.13	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	47.13	9.25	1.49	4.18	1.94	0.89	1.34	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	101.50	21.33	5.28	4.24	2.06	0.57	1.15	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	97.72	29.94	5.39	6.77	1.88	1.00	2.00	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	102.87	24.81	4.67	5.12	1.37	0.57	1.59	0.34
Basophils, donor1	12241-129G9	20.92	4.71	0.78	0.26	0.52	0.00	0.78	0.00
Basophils, donor2	12242-129H1	35.36	5.77	1.08	2.53	0.36	0.00	1.44	0.00
Basophils, donor3	12243-129H2	37.78	5.29	1.18	1.76	0.29	0.29	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	9.70	2.16	1.29	0.43	0.22	0.22	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.91	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	3.77	3.14	0.63	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	15.39	3.95	2.50	1.25	0.83	0.42	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	11.05	2.07	0.46	0.46	0.23	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.91	1.44	0.90	0.90	0.00	1.08	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	34.21	18.03	2.89	2.16	1.34	1.13	2.06	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	32.84	13.97	3.03	2.33	2.79	0.23	2.79	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	56.28	8.95	3.52	2.88	0.64	0.96	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	29.87	9.58	0.56	0.00	0.00	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	54.38	12.81	2.23	0.93	0.93	0.56	1.48	0.37
CD14+ Monocytes, donor3	11381-118B4	50.93	11.42	1.76	1.32	0.66	0.00	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	35.66	2.26	1.13	0.85	2.26	0.28	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	38.67	4.55	0.76	3.41	1.52	0.00	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	51.94	3.29	1.64	2.96	0.33	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	51.46	1.88	1.01	2.17	0.87	0.00	0.29	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	42.24	2.41	1.21	0.91	0.60	0.00	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	58.75	2.13	1.18	0.95	1.90	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	39.84	1.84	0.84	0.84	0.67	0.00	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	39.75	3.31	0.28	1.10	1.10	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	47.60	2.73	0.50	0.50	0.25	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	28.59	0.78	0.20	0.39	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	40.24	1.07	0.36	0.53	0.18	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	21.33	0.00	0.00	0.22	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	33.01	3.28	0.00	0.47	0.70	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	47.52	3.17	0.53	0.53	0.53	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	4.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	35.10	2.53	0.45	0.30	1.34	0.00	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	30.53	3.19	1.40	1.40	0.60	0.40	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	22.07	1.46	0.42	0.42	0.42	0.00	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.66	2.06	0.69	0.23	0.46	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	29.41	2.71	0.45	0.68	0.68	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	33.61	3.06	0.00	0.44	0.87	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	37.93	0.81	0.27	1.08	0.54	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	46.93	0.52	0.70	0.52	0.70	0.17	0.00	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	53.87	0.42	0.00	0.84	1.26	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	31.60	1.29	0.18	0.92	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	41.57	3.87	0.35	1.06	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	39.05	3.07	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.64	1.22	0.35	0.35	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	46.83	2.97	0.37	0.74	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.70	0.86	0.43	0.22	0.43	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	33.17	2.46	0.82	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	24.80	1.62	0.23	0.46	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.86	0.93	0.23	0.00	0.46	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	11.77	1.53	1.74	0.65	0.87	0.00	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	17.32	2.08	1.62	0.46	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	13.43	0.22	1.30	0.00	0.43	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	30.21	1.09	0.78	1.09	0.16	0.16	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	24.80	1.05	0.87	0.70	0.70	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	49.50	3.57	2.68	2.68	1.56	1.11	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	15.82	0.51	1.28	0.77	0.26	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	21.08	0.44	1.32	0.66	0.22	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	14.53	1.47	1.05	0.63	0.42	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	6.10	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	47.46	9.49	2.03	2.03	1.36	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	11.39	5.18	2.07	2.07	0.00	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	38.91	11.19	3.20	3.20	1.60	1.07	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	45.57	16.62	2.68	7.50	1.61	1.07	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	43.52	14.74	3.51	2.81	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	45.49	21.96	3.14	4.71	1.57	1.57	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	48.78	18.46	2.64	3.95	0.00	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	55.07	25.48	4.11	3.29	1.64	0.00	4.11	0.00
CD19+ B Cells, donor2	11624-122B4	39.17	21.76	2.18	4.35	0.73	0.73	2.90	0.00
CD19+ B Cells, donor3	11705-123B4	42.91	36.85	2.52	3.03	1.51	0.00	3.53	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	39.19	2.83	5.66	1.21	0.81	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	24.37	2.40	1.20	1.20	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	35.14	7.03	7.03	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	54.50	13.48	5.62	1.12	2.25	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	40.96	5.26	5.26	4.88	1.50	0.75	1.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	54.79	6.99	2.48	1.58	1.35	0.90	0.90	0.23
CD4+ T Cells, donor1	11225-116C1	71.77	35.35	8.57	3.21	1.79	0.00	5.36	0.36
CD4+ T Cells, donor2	11306-117C1	73.48	28.17	5.51	3.67	2.45	2.45	4.90	0.00
CD4+ T Cells, donor3	11382-118B5	45.44	13.42	2.74	1.22	1.52	0.91	2.74	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	49.26	2.55	3.83	2.55	1.02	0.77	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.27	6.29	3.59	2.92	1.35	0.00	0.22	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	48.29	4.89	3.16	1.44	1.15	0.00	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	45.51	11.38	3.79	0.95	1.42	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	49.86	11.24	2.81	0.70	0.70	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	9.89	3.30	3.30	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	31.50	5.64	3.76	1.30	1.01	0.29	0.00	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.54	4.24	3.05	1.86	2.20	0.34	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.92	3.55	2.10	2.74	1.45	0.32	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.93	5.38	1.34	1.34	1.79	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	37.73	4.89	1.75	0.70	1.05	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.16	6.60	2.64	1.32	1.76	0.44	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.47	6.75	1.69	3.37	2.11	1.26	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.59	2.70	2.08	2.08	0.83	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	32.74	4.01	1.34	1.67	1.34	0.33	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	51.67	11.97	3.26	3.81	0.82	0.54	1.36	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	70.21	18.22	3.75	5.36	2.14	0.54	2.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	10.76	5.38	1.79	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	49.14	6.12	3.15	2.60	0.56	0.37	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	34.01	3.03	2.38	1.73	0.65	0.43	0.65	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.72	3.57	1.89	1.89	1.47	0.42	0.42	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	47.53	9.10	3.03	1.52	1.52	0.00	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	36.39	7.80	3.03	1.30	0.87	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	50.12	6.10	1.74	1.74	0.44	0.87	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.94	18.81	3.96	3.46	1.48	0.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	7.39	1.85	3.69	0.00	1.85	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	50.25	6.98	5.58	1.40	1.40	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	59.54	14.95	3.88	5.54	1.94	0.28	1.66	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	62.57	14.48	6.87	3.93	1.47	0.98	1.23	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	44.66	9.24	4.62	7.70	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	53.00	10.03	4.30	5.37	1.43	0.72	1.43	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	48.47	12.46	1.38	8.31	0.00	4.15	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	49.76	23.57	5.57	1.96	1.96	0.65	3.93	0.33
CD8+ T Cells, donor2	11307-117C2	49.18	22.90	6.01	3.00	1.13	0.00	2.63	0.75
CD8+ T Cells, donor3	11383-118B6	69.18	37.87	5.55	6.06	3.03	0.76	5.30	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.88	7.34	5.73	0.69	0.69	0.46	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.75	5.27	5.75	1.68	0.48	0.48	0.96	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.29	7.39	6.57	0.55	0.55	0.82	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.61	6.30	4.80	0.30	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.96	5.52	5.04	0.96	0.24	0.24	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.73	10.23	6.82	0.45	0.68	0.23	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.39	8.69	4.78	0.65	0.22	0.22	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.11	8.69	6.05	0.26	0.79	0.53	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.86	11.02	8.68	0.47	0.23	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.36	6.94	4.53	1.21	0.00	0.60	1.51	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.39	10.46	3.20	0.58	0.58	0.29	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.79	6.13	6.66	0.00	0.53	0.27	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	5.69	10.94	10.51	0.44	0.44	0.00	1.75	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.29	10.02	9.11	0.91	0.46	1.82	1.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	20.88	14.17	0.75	0.75	1.49	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.20	7.20	4.68	0.36	0.36	0.72	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.51	5.18	7.19	0.86	0.29	0.86	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.43	8.49	5.89	0.94	0.71	1.18	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.77	6.02	4.44	0.95	0.95	0.95	1.90	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	9.84	7.38	1.23	0.31	0.92	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7.69	10.90	9.30	1.60	0.00	1.60	1.92	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.59	9.18	5.74	1.15	0.38	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	6.31	10.25	4.34	0.79	0.79	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	9.83	2.27	0.76	0.76	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	18.47	3.21	1.61	0.00	0.00	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	23.08	4.20	2.10	0.70	0.00	2.80	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	22.04	10.02	0.00	0.00	1.00	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	31.07	3.66	0.00	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	2.47	1.48	1.98	0.49	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	13.79	2.10	1.05	1.16	0.11	0.21	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	18.72	3.81	0.00	0.35	0.00	0.35	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	19.55	1.42	1.78	1.07	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	18.77	1.37	0.68	0.34	0.11	0.57	0.11	0.46
Chondrocyte - re diff, donor2	11339-117F7	22.38	6.27	2.69	0.90	0.00	2.69	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	22.24	1.21	1.21	0.81	0.81	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	44.18	5.62	2.75	1.72	1.61	1.49	0.46	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	37.20	6.63	1.71	2.99	1.50	0.64	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	37.88	7.79	2.57	2.74	0.97	0.62	0.35	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	66.48	6.14	2.57	3.76	3.21	0.83	1.10	1.28
Corneal Epithelial Cells, donor1	11526-119I5	8.56	2.20	1.54	0.66	0.22	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	1.14	3.41	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.87	5.11	1.28	0.77	0.51	0.51	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.96	2.15	1.82	0.33	0.66	0.66	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.71	1.89	1.58	0.63	1.26	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	0.00	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.60	2.81	1.40	0.43	0.32	0.54	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.21	7.17	1.37	2.05	1.71	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	40.48	8.49	1.31	1.31	0.65	0.00	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	39.20	11.61	3.39	1.45	0.97	0.48	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	14.51	2.17	2.00	0.00	0.50	0.33	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	12.91	2.35	1.76	0.59	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	20.64	3.96	0.85	1.70	0.85	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	20.05	2.36	2.36	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	16.87	3.49	2.33	1.16	0.87	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	26.82	4.00	2.12	0.94	0.71	0.47	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	18.58	3.16	1.75	1.23	0.70	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.39	0.66	0.89	0.66	0.44	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.78	1.52	1.22	0.30	0.30	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.55	1.69	2.54	1.69	0.28	0.28	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	14.56	1.19	0.00	0.89	0.59	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	1.04	1.56	1.04	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	17.01	2.13	1.28	0.85	0.85	0.57	0.28	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	26.01	7.20	2.80	0.40	0.40	0.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	14.15	2.10	0.00	2.10	0.52	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	35.41	7.70	3.35	1.62	2.11	0.87	0.50	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	54.10	5.87	2.61	2.82	0.65	0.87	0.22	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	52.76	7.82	3.05	2.20	1.47	0.85	0.49	0.12
Endothelial Cells - Vein, donor1	11267-116G7	11.38	4.55	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.76	1.40	2.10	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.24	2.51	1.73	1.41	1.26	0.31	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	77.56	16.50	0.00	1.65	0.00	0.00	3.30	1.65
Eosinophils, donor3	12246-129H5	92.74	7.13	0.00	7.13	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.31	0.98	1.47	0.00	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	1.23	0.41	0.00	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.38	0.99	0.44	0.00	0.11	0.33	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.46	2.17	1.41	0.54	0.43	0.11	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.80	3.03	1.33	0.24	1.09	0.61	0.00	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	14.06	2.32	1.91	1.09	0.41	0.14	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.93	1.27	0.95	0.53	0.74	0.21	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	36.89	5.01	2.11	2.11	0.79	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.90	2.99	0.33	1.00	0.66	0.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	20.87	3.63	1.81	2.72	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.89	3.03	3.03	0.00	0.00	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	11.36	2.68	0.47	0.79	0.00	0.47	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	40.31	3.94	3.03	3.33	2.42	0.61	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	19.80	2.16	1.78	1.14	0.38	0.76	0.13	0.38
Fibroblast - Cardiac, donor6	11460-119B2	17.74	4.70	1.97	1.06	0.45	0.45	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.18	2.01	1.21	0.80	0.80	0.40	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	2.59	1.29	2.16	0.86	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	4.39	0.00	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	25.37	7.38	2.77	2.31	1.15	0.23	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	29.00	3.05	4.24	0.51	1.02	0.34	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	19.96	1.41	3.05	0.70	0.94	0.70	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	8.96	0.94	2.36	0.94	0.00	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.14	1.93	1.93	0.48	0.48	1.09	0.12	0.36
Fibroblast - Dermal, donor4	11450-119A1	33.69	8.93	3.28	2.83	2.15	1.36	0.57	0.11
Fibroblast - Dermal, donor5	11454-119A5	30.01	11.69	4.19	1.74	1.40	0.87	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	24.85	9.75	5.04	2.60	0.81	0.97	0.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	34.57	3.12	1.87	0.62	0.21	0.62	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.47	3.93	3.93	1.83	1.57	1.57	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	29.65	8.96	4.22	2.11	1.58	1.32	0.13	0.13
Fibroblast - Gingival, donor3	11394-118C8	62.65	3.38	2.71	0.97	1.26	0.77	0.29	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	2.08	3.12	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.42	6.52	1.76	2.11	1.41	2.11	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	42.87	9.98	5.14	1.87	1.09	1.25	0.62	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	29.48	6.76	3.11	1.08	1.62	0.68	0.41	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	164.09	31.76	10.59	13.06	10.94	1.06	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.95	5.26	2.19	0.58	1.61	1.02	0.15	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.13	3.27	1.91	1.50	1.91	0.55	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	42.23	11.96	6.03	2.08	2.74	1.43	0.44	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	51.80	7.78	3.08	4.11	3.37	1.03	0.59	0.44
Fibroblast - Lung, donor1	11270-116H1	10.87	0.00	1.36	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	2.98	0.00	1.49	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	27.01	4.64	2.53	0.63	0.63	0.42	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	23.32	1.67	0.83	0.83	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	4.20	1.40	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	0.84	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	34.10	7.71	2.84	1.62	2.44	0.81	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	19.97	7.99	7.99	0.00	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	5.96	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	28.32	8.53	2.52	2.33	0.78	1.16	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	55.67	15.02	6.22	4.10	4.10	1.21	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.37	9.49	1.84	3.37	1.22	0.61	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	49.99	4.96	6.11	0.76	1.14	0.76	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.44	2.97	0.54	0.81	0.00	0.00	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	37.81	4.06	1.51	1.97	1.62	0.12	0.35	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.40	1.88	1.44	0.77	0.11	0.22	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	33.32	1.83	1.83	0.81	0.61	0.81	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	1.34	0.67	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	2.37	2.77	0.40	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	51.20	3.77	3.97	1.59	0.40	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.76	2.13	1.60	0.18	0.36	0.53	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.71	0.79	0.59	0.39	0.39	0.20	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	26.78	6.92	2.71	0.90	0.60	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	27.85	2.70	1.30	0.86	0.65	0.32	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	33.41	1.27	2.28	0.25	0.25	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	18.38	1.15	0.82	0.98	0.66	0.82	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	36.89	5.21	4.01	1.80	1.20	0.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	20.19	2.31	2.31	0.30	0.80	0.40	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	44.73	5.44	2.12	1.81	1.21	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.04	1.82	2.24	0.25	0.50	0.50	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.09	1.54	2.39	1.03	0.51	0.51	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.73	4.60	1.31	1.31	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.88	2.02	1.81	1.07	0.64	0.75	0.53	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	20.41	3.20	2.19	0.34	0.51	0.51	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.78	0.63	1.41	0.31	0.00	0.16	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	37.48	3.49	6.10	3.49	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.16	3.47	1.91	0.87	0.17	1.21	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.26	3.90	1.82	1.82	0.52	0.26	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.06	7.67	2.04	2.04	0.77	0.77	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	44.40	29.86	7.66	15.31	6.89	0.77	0.77	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	26.16	6.38	6.38	9.57	1.91	0.64	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	61.90	20.82	3.14	4.56	5.13	0.00	1.43	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	133.19	41.64	7.17	27.30	28.68	1.10	1.93	4.96
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	73.98	19.41	3.20	9.82	10.27	1.14	1.14	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	70.73	28.33	4.76	11.49	9.31	0.40	0.99	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	112.61	38.86	6.61	17.45	24.05	1.06	1.32	5.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	70.12	26.42	9.46	10.44	15.00	1.96	1.96	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	40.68	21.67	2.21	4.42	3.10	0.00	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	55.54	14.27	3.53	4.52	4.80	0.42	1.13	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	57.75	19.83	3.69	4.43	3.69	0.62	0.12	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	37.61	19.34	5.64	7.52	5.10	0.27	0.54	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	42.62	14.12	1.49	4.21	2.60	0.50	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.53	9.97	2.49	3.88	2.77	0.83	0.42	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	30.90	10.98	2.44	3.05	1.42	0.00	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.58	8.44	3.65	1.83	1.14	0.46	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.24	6.98	1.37	2.87	1.25	0.37	0.37	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	59.67	11.58	2.84	3.72	1.31	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.09	10.34	2.36	2.95	3.84	0.30	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	49.28	10.33	2.38	3.18	3.02	0.95	1.27	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	51.16	12.96	0.89	3.57	1.12	0.67	0.22	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	48.39	9.88	2.42	1.81	2.22	0.20	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	50.38	9.84	2.54	2.54	3.05	0.17	0.68	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	44.60	13.57	2.93	2.13	3.46	0.44	1.15	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	84.81	10.30	2.19	3.02	4.16	0.21	0.73	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	67.12	12.13	2.56	3.76	4.10	0.51	0.34	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	63.40	6.97	1.88	2.10	1.77	0.22	0.33	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.35	9.82	2.08	2.58	2.91	0.25	0.42	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.10	8.78	2.25	1.84	1.43	0.82	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.69	7.22	1.86	2.27	1.65	0.21	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	63.41	7.84	1.61	1.73	2.19	0.46	0.23	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	50.03	8.84	1.00	3.34	1.50	0.83	0.50	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	50.70	7.27	3.31	3.75	3.75	1.10	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	64.82	4.30	1.60	1.35	1.97	0.25	0.49	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.90	7.78	1.62	2.11	1.78	0.65	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	59.97	7.38	0.96	2.89	1.92	0.00	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	47.47	5.12	1.04	2.56	1.61	0.38	0.47	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	41.60	6.96	1.11	2.37	0.47	0.63	0.47	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	53.52	6.08	2.74	2.74	2.43	0.30	0.61	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	46.52	6.79	0.73	2.09	2.09	0.63	0.42	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	40.18	4.83	1.10	1.76	2.42	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	53.30	8.14	0.00	3.37	0.28	1.12	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.46	6.76	2.13	2.50	1.85	0.83	0.46	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.80	4.81	0.80	3.48	0.53	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.72	8.42	2.91	1.99	1.38	0.61	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	31.22	5.18	1.30	0.91	2.07	0.78	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	40.93	5.69	1.08	2.17	1.08	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.76	6.08	2.03	1.29	1.84	0.37	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	42.11	5.70	1.97	1.75	1.54	0.22	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	174.55	14.88	6.94	7.93	8.93	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	35.09	5.80	2.51	1.85	1.58	0.53	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.30	4.64	1.61	1.41	2.02	0.61	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	137.75	11.18	3.05	4.07	5.34	0.25	0.51	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	60.32	27.07	6.17	6.57	6.57	1.39	1.19	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	64.71	28.50	4.93	6.63	5.55	0.31	1.54	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	76.72	37.44	6.34	14.32	11.25	0.61	1.84	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.40	14.39	1.25	3.13	2.82	0.94	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.50	14.69	2.26	3.11	2.54	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	36.44	16.60	2.77	9.69	4.15	0.46	0.46	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	29.70	4.95	2.47	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	42.55	20.50	4.64	8.51	5.42	0.77	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	38.51	35.30	4.81	9.63	1.60	8.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	22.60	3.48	5.22	5.22	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	48.50	15.30	5.21	4.88	1.30	0.98	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	51.48	17.30	5.35	8.65	2.47	1.24	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	63.31	39.99	10.00	26.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	45.02	17.90	3.36	6.99	2.52	0.28	1.12	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	43.80	14.38	3.92	5.23	3.27	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	63.75	21.81	1.68	5.87	5.03	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	59.16	18.13	2.86	3.82	4.77	0.64	0.32	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.72	12.91	3.40	4.76	2.38	0.34	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	22.97	0.00	4.18	6.26	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.86	8.59	4.58	4.58	2.86	0.57	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	42.03	9.47	1.78	2.96	1.48	0.00	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	6.78	0.00	3.39	3.39	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	50.12	12.84	4.56	4.56	2.49	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	52.93	15.42	4.37	7.13	3.91	0.92	0.23	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	41.52	8.84	1.54	3.08	1.92	0.00	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.92	9.78	2.28	3.26	2.28	0.00	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	28.09	8.03	1.34	2.01	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.44	8.09	1.54	4.62	3.85	0.00	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	82.85	21.91	3.42	7.53	4.45	3.42	1.03	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	12.42	9.94	9.94	4.97	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	81.16	9.91	1.89	4.25	2.83	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	64.57	6.64	3.02	3.02	2.41	0.00	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	69.69	12.72	2.03	6.10	3.05	1.02	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	61.42	9.97	3.99	3.19	3.19	0.00	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	59.20	7.40	1.97	2.96	2.47	0.00	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	49.58	11.80	2.36	3.54	2.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	36.17	7.58	0.00	1.75	1.75	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	64.52	5.27	2.63	2.63	2.19	0.00	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	71.21	4.24	5.09	3.39	0.85	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	9.55	1.79	4.18	1.79	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	35.91	4.37	3.40	1.94	2.91	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	25.11	1.14	3.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.86	2.49	1.25	0.00	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	17.99	3.37	1.12	0.00	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.22	0.95	1.59	0.00	0.63	0.32	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.19	1.25	0.84	0.00	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.86	4.64	1.74	0.93	0.93	0.46	0.70	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	25.49	5.57	2.03	1.18	0.34	0.51	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.61	3.19	2.73	1.82	0.91	0.23	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	22.52	3.28	1.97	0.98	1.20	0.55	0.55	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	25.36	4.51	1.93	0.86	1.93	0.64	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.97	5.60	3.23	1.72	1.51	0.43	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.55	3.24	1.25	0.75	0.87	0.50	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.56	1.54	1.20	0.69	0.51	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	15.38	2.56	2.24	0.00	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	33.02	2.80	1.12	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.55	1.30	0.00	1.30	1.73	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	17.64	2.12	2.12	1.06	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.98	1.45	0.73	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.49	4.37	1.75	1.40	1.40	0.00	0.35	0.00
Hepatocyte, donor1	11523-119I2	37.53	0.00	3.63	1.21	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	35.55	6.46	3.23	1.08	4.31	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	34.97	1.84	1.23	0.61	1.84	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	67.23	23.50	7.18	3.92	4.57	1.96	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	66.42	17.30	6.12	4.89	3.15	1.05	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.39	2.06	0.69	1.78	0.27	0.00	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	111.44	9.55	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	54.17	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	40.15	4.15	2.77	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	0.00	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	102.52	5.13	0.00	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	76.34	3.25	1.62	3.25	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	5.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	6.62	1.32	3.97	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	35.48	4.43	1.11	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	5.24	5.24	5.24	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	63.62	1.89	0.63	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	55.68	6.19	0.00	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	76.23	3.23	0.00	2.58	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	82.11	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	62.75	4.89	0.81	0.00	2.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.73	2.52	1.68	1.68	1.26	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	52.24	3.21	0.00	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	45.24	4.62	1.85	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.99	2.83	2.36	0.47	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	39.91	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	63.49	4.30	2.15	2.15	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	67.33	6.35	1.27	2.54	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	75.25	2.55	1.28	1.91	1.91	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	72.91	7.29	5.47	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	59.98	1.43	0.00	2.14	1.43	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	109.50	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	36.11	5.56	1.54	0.93	0.93	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	7.02	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	62.58	3.48	0.70	1.39	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	53.11	4.43	2.21	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	9.73	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	46.21	5.23	0.87	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	78.74	0.00	0.00	0.00	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	3.48	6.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	8.53	1.07	1.07	1.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	49.88	4.16	1.39	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	0.00	2.85	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	84.68	4.60	0.00	1.84	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	33.84	6.34	0.00	1.06	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	17.22	3.67	3.10	0.33	0.82	0.82	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	7.61	0.59	0.00	0.00	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	19.78	5.58	1.33	1.42	1.23	0.57	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	45.29	4.65	3.52	1.82	1.70	0.79	0.23	0.11
Keratocytes, donor1	11527-119I6	11.69	2.75	0.34	0.34	1.38	0.34	0.34	0.00
Keratocytes, donor2	11607-120I5	14.06	1.17	3.52	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	38.93	4.15	0.99	1.19	1.19	0.00	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	83.52	2.20	10.99	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	17.26	2.16	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.68	2.31	0.69	1.50	0.92	0.35	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	29.26	6.46	2.72	3.13	1.51	0.81	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.64	1.42	1.30	0.83	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.44	1.67	0.00	0.28	0.00	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.63	1.57	0.63	1.10	0.79	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	1.08	0.00	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.35	2.84	0.32	0.63	0.32	0.63	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.70	0.97	0.54	0.65	0.43	0.11	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.13	0.82	0.41	1.23	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.86	0.76	0.00	0.00	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.68	2.39	0.70	0.28	0.28	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.07	1.98	1.19	0.79	0.79	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.80	1.55	0.39	0.39	0.78	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.11	0.74	0.19	0.00	0.74	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.54	2.09	0.35	0.70	0.35	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	1.67	0.72	0.00	0.72	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.93	1.24	0.55	0.69	0.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	1.85	2.77	0.00	0.31	1.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.23	0.31	0.94	0.00	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.08	1.46	0.73	1.10	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.54	1.32	0.33	0.33	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.27	0.59	0.00	0.00	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.21	1.00	0.75	0.25	0.00	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.61	1.45	0.48	1.45	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.46	1.35	0.81	0.00	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.54	1.97	1.36	1.21	0.45	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	1.04	2.59	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.03	1.26	0.63	0.63	0.63	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.38	1.20	0.75	0.75	0.45	0.15	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	2.75	0.00	0.00	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.61	2.63	0.94	0.38	0.56	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.07	0.95	1.59	0.00	0.42	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	2.42	2.42	0.97	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.59	0.99	0.33	0.66	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.65	0.62	0.62	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.70	1.48	1.85	0.74	0.37	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.61	1.73	0.74	0.00	0.49	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.59	0.96	1.10	0.55	0.00	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.44	1.61	1.29	0.00	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.00	2.74	1.22	0.61	1.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	15.96	1.96	1.12	0.56	0.70	0.28	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	2.84	0.36	1.07	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	2.91	0.48	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.94	0.62	0.00	0.16	0.31	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.39	0.36	1.07	0.72	0.72	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.27	1.63	1.96	1.31	0.33	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.18	1.18	0.00	0.00	0.71	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.48	2.60	0.87	1.24	0.74	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.01	0.77	0.00	0.00	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.14	0.90	0.90	0.60	0.30	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	79.31	13.60	6.80	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	94.36	13.81	11.51	1.53	3.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	87.58	10.39	5.94	4.45	2.97	2.97	0.74	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	93.09	16.93	8.89	2.12	3.81	2.12	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	99.87	9.85	6.33	7.03	2.11	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	77.52	6.54	8.41	0.93	0.93	0.93	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	72.65	10.82	8.24	2.06	3.61	1.03	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	109.43	11.89	7.14	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	66.50	10.63	6.11	3.62	2.26	1.36	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	82.01	11.92	8.43	4.65	2.33	2.62	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	93.19	10.35	6.75	4.05	2.25	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	87.39	16.39	8.26	4.74	2.85	2.85	1.49	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	90.89	12.84	10.78	3.59	1.54	1.03	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	91.04	13.41	4.23	4.59	2.47	1.06	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	73.96	10.66	9.33	3.33	1.33	2.00	2.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	94.24	14.77	6.11	2.55	2.04	0.00	1.02	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	95.25	15.74	6.94	3.74	1.87	1.07	1.87	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	110.34	15.12	8.12	4.53	1.51	0.76	0.94	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	93.88	12.88	6.75	2.45	3.68	0.61	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	140.25	14.68	10.60	3.26	4.89	2.45	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	97.67	19.78	6.46	4.58	2.92	2.71	0.21	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	84.92	11.77	9.25	4.20	2.24	3.08	1.12	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	119.52	14.42	8.24	7.21	0.00	2.06	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	97.83	17.42	8.13	6.68	3.19	2.61	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	67.86	13.15	5.98	3.59	2.69	2.69	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	80.78	10.51	3.32	8.85	0.55	3.32	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	133.26	14.85	9.54	8.48	3.18	0.71	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	94.78	18.81	11.80	4.43	2.58	2.21	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	90.95	12.66	11.51	5.76	1.15	3.45	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	100.93	20.72	7.68	7.29	3.07	0.77	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	97.37	15.29	7.93	5.10	1.13	3.40	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	101.74	15.59	7.38	6.56	2.46	0.82	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	101.22	18.98	7.68	7.68	1.81	0.45	0.45	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	83.30	12.93	5.03	6.46	1.44	0.72	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	116.52	12.70	10.46	5.23	0.75	1.49	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	108.88	20.07	6.32	5.57	1.49	1.49	2.23	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	77.53	10.77	5.60	3.45	2.58	3.02	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	101.90	11.99	3.43	9.42	0.00	1.71	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	120.94	16.33	6.66	3.66	2.67	2.00	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	80.84	12.07	9.05	3.02	3.02	0.60	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	130.82	11.38	7.11	3.55	2.13	1.42	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	112.40	12.72	5.16	4.47	1.72	2.41	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	95.54	19.32	8.05	3.22	1.07	0.54	2.68	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	142.75	12.12	4.04	7.41	2.02	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	132.24	13.33	9.63	5.19	1.85	1.48	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	67.45	5.81	6.98	3.49	3.49	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	135.39	12.69	8.46	3.17	1.06	0.00	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	121.65	14.41	6.80	4.80	4.00	2.00	1.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	79.96	15.99	10.18	3.63	1.45	3.63	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	134.91	15.33	9.20	6.13	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	119.87	18.74	10.36	6.41	3.95	2.96	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	97.86	9.41	8.47	1.88	2.82	3.76	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	125.20	21.62	6.54	8.05	2.51	1.01	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	112.66	18.93	4.51	4.96	2.70	1.80	1.80	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	65.40	12.05	8.61	6.88	1.72	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	132.27	22.71	9.80	10.24	2.67	1.78	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	122.78	21.51	11.34	5.47	4.69	2.74	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	83.79	23.09	5.94	5.28	2.64	0.66	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	133.36	16.61	7.78	4.67	1.56	4.67	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	153.59	22.32	9.63	4.81	7.00	1.75	0.00	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	90.57	11.74	5.59	2.80	2.80	2.24	1.12	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	124.54	15.46	10.16	3.53	2.65	2.21	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	117.26	15.43	7.71	6.56	4.24	2.70	0.77	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	85.07	21.77	8.61	8.10	3.04	1.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	128.81	13.94	9.61	6.73	1.92	0.48	1.92	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	101.77	13.52	9.54	7.95	2.78	1.19	0.00	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	90.54	20.66	9.72	6.68	4.25	3.04	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	81.62	9.68	9.68	3.46	2.08	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	121.60	15.58	7.22	7.60	3.42	1.14	0.76	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	98.12	20.14	10.84	2.58	2.07	1.03	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	81.63	17.53	8.47	4.84	1.81	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	109.96	19.65	8.87	6.02	5.07	1.58	0.32	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	83.69	19.19	14.39	4.80	2.13	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	80.45	18.96	10.34	2.87	4.02	2.30	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	116.73	22.63	9.77	8.74	2.06	3.09	1.03	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.98	25.46	9.20	7.07	2.83	2.12	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	80.02	23.27	10.21	3.97	3.40	1.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	109.00	18.31	10.82	7.07	2.50	1.66	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	75.17	28.97	12.53	7.83	3.92	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	73.49	26.72	11.27	7.10	1.25	0.84	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	100.83	25.56	9.29	10.69	3.25	1.86	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	68.24	23.42	12.71	5.35	3.35	2.68	2.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	85.54	28.34	11.76	9.09	4.81	1.60	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	100.22	30.71	12.93	10.51	4.04	1.62	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	84.43	30.29	11.01	3.67	3.67	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	109.36	26.67	10.67	3.56	6.22	1.78	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	128.22	28.49	11.40	13.11	3.99	1.14	3.99	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	102.76	19.17	13.80	5.37	3.83	3.07	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	101.77	26.26	10.40	7.66	2.74	1.64	2.19	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	118.93	30.29	11.14	8.46	2.23	2.23	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	91.24	20.02	11.70	7.80	3.38	3.64	2.08	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	109.41	27.19	17.24	3.98	2.65	1.33	1.33	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	160.05	37.41	14.55	6.24	2.08	10.39	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.14	1.37	1.37	1.37	0.23	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	12.48	0.18	2.02	0.55	0.18	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	26.22	2.62	1.44	0.79	0.26	0.66	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.31	2.12	2.12	0.53	0.00	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	15.85	2.06	2.85	0.48	0.79	0.32	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	15.43	2.78	2.92	0.69	0.28	0.42	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	25.61	7.77	3.19	1.49	2.09	0.80	0.40	0.00
Mammary Epithelial Cell, donor2	11350-117G9	23.16	2.90	4.92	1.16	0.87	0.58	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	13.47	2.24	2.00	0.00	0.50	1.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	35.25	4.75	10.17	2.03	6.10	2.03	0.00	0.68
Mast cell, donor1	11563-120D6	43.15	4.76	1.62	3.57	1.73	1.08	0.32	1.08
Mast cell, donor2	11565-120D8	56.17	13.08	8.92	8.62	4.16	1.49	2.67	1.78
Mast cell, donor3	11566-120D9	67.31	15.08	4.95	5.63	4.95	0.45	0.45	2.93
Mast cell, donor4	11567-120E1	57.62	11.17	6.56	7.09	3.72	2.13	1.60	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	44.58	3.44	2.55	2.22	2.44	0.44	0.22	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	19.85	5.25	2.92	0.58	1.17	1.75	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	28.80	2.18	2.64	2.52	0.80	0.57	0.00	1.38
Mast cell, expanded, donor8	11941-126A6	44.35	5.69	4.18	3.18	3.01	0.17	0.17	1.00
Melanocyte - dark, donor1	11502-119F8	15.92	0.99	0.70	1.39	0.20	0.10	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	22.15	2.08	2.42	1.04	1.04	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	27.60	7.03	1.52	2.10	0.65	0.36	0.36	0.00
Melanocyte - light, donor1	11274-116H5	25.86	4.70	1.41	1.41	1.41	0.24	0.24	1.18
Melanocyte - light, donor2	11351-117H1	25.25	4.09	0.68	0.00	0.68	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	18.21	1.73	0.87	0.87	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	29.16	3.23	1.98	1.04	0.83	0.52	0.21	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	20.98	3.50	2.42	0.81	0.27	0.81	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	46.87	3.48	3.21	1.07	2.14	0.00	0.54	1.07
Meningeal Cells, donor1	11493-119E8	29.90	7.57	2.98	1.49	1.24	0.87	0.74	0.00
Meningeal Cells, donor2	11573-120E7	31.69	9.68	2.20	0.44	0.44	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	25.18	7.25	3.10	2.28	1.39	0.90	0.49	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	20.82	5.42	1.14	1.43	0.86	0.86	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.27	1.31	0.81	0.20	0.20	0.50	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	1.31	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	18.31	1.31	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	2.87	5.02	2.15	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	19.27	1.06	0.42	0.64	1.06	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	20.11	1.51	0.50	1.01	1.01	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.70	3.96	3.52	0.88	0.22	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.92	2.92	1.46	0.73	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.85	3.07	3.48	1.02	0.00	0.61	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	17.17	1.66	2.22	0.69	0.00	0.14	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.52	0.37	0.37	0.00	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.92	1.45	0.79	0.79	0.66	0.13	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.62	0.89	0.59	0.89	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	2.34	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	22.41	3.20	0.64	0.00	1.92	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.05	3.19	1.42	0.00	0.71	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	0.94	0.63	0.63	0.63	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	7.26	0.73	2.18	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.79	2.12	0.80	1.33	0.80	0.27	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	15.01	3.00	0.50	1.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	20.31	3.54	2.24	0.65	0.22	0.36	0.36	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	62.11	4.05	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.40	1.72	1.97	0.74	0.99	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.91	2.06	1.77	0.88	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	2.48	0.31	0.62	0.62	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.12	0.41	1.24	0.41	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	4.63	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.53	2.00	1.00	0.25	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	27.00	0.93	0.93	0.47	0.47	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	22.35	1.63	0.81	0.61	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	0.79	0.00	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	0.00	0.88	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	1.14	0.00	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	6.58	0.00	1.32	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.43	0.64	0.21	0.21	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	0.00	0.92	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.22	1.49	0.30	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	0.50	0.00	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.26	1.19	0.71	0.24	0.24	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	1.11	0.55	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	0.92	0.23	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.68	1.05	0.42	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	1.43	0.61	0.41	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.87	1.72	0.21	0.21	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.34	1.11	0.22	0.44	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.48	0.88	0.44	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	1.52	1.01	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.70	1.36	0.27	0.54	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.35	1.47	0.59	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	0.00	1.09	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.77	0.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	2.74	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.13	0.88	0.44	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.33	3.20	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.94	0.99	0.00	0.25	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	1.39	0.00	0.00	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	13.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.91	1.03	0.00	1.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	1.31	0.88	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	22.73	3.55	1.07	0.71	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.45	0.84	0.28	0.84	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	1.66	0.00	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	6.41	2.91	1.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.95	3.02	0.60	0.60	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	1.25	0.42	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	1.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.09	4.55	0.57	1.71	0.57	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.44	3.73	0.14	0.55	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.18	1.30	0.52	0.26	0.26	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.45	3.43	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	21.60	5.08	0.64	1.27	1.27	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.41	4.27	0.27	1.07	0.27	0.27	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.17	3.29	2.10	1.50	0.60	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.07	3.81	0.42	0.57	0.28	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	1.27	0.00	0.32	0.00	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.37	1.77	0.88	0.66	0.66	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.06	5.31	0.76	1.52	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	2.27	0.28	0.57	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.06	4.18	0.49	0.00	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	25.42	9.78	3.26	0.65	0.00	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.82	3.23	0.29	0.88	0.00	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.01	4.04	0.58	1.15	0.00	1.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.43	4.12	1.65	2.47	1.65	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.61	2.98	0.60	0.30	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	0.00	1.78	1.78	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.43	0.33	0.66	1.64	0.66	0.66	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	2.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.12	0.99	0.40	0.00	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	0.93	1.86	3.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.27	1.88	0.75	1.50	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.06	0.80	0.27	0.27	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.26	1.02	0.45	0.68	0.34	0.23	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	0.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.73	1.47	0.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	1.56	1.56	3.11	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	3.03	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.54	0.42	0.00	0.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	6.52	3.26	3.26	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.87	2.37	1.51	0.65	0.22	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.88	3.14	0.52	1.05	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	2.00	2.00	3.34	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.95	4.59	2.92	1.67	1.25	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	58.18	6.65	2.47	2.47	2.66	0.38	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	79.79	7.98	6.38	4.79	1.60	4.79	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	2.04	1.36	0.68	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	137.82	0.00	5.51	7.35	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.39	1.67	3.35	1.26	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	2.32	1.16	0.70	0.93	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.37	2.70	3.78	1.35	1.08	0.54	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	47.93	2.94	2.94	2.31	2.10	0.42	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	1.49	1.49	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.30	0.81	0.27	0.54	0.54	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.33	1.59	1.13	0.23	0.23	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.15	2.61	2.45	0.82	0.65	0.98	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	40.28	2.55	2.19	1.64	1.09	0.18	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.16	0.53	2.12	0.00	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	2.40	0.60	1.20	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	57.43	1.97	1.31	1.64	1.97	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.64	2.44	1.63	0.65	0.49	0.65	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	65.26	5.64	2.65	1.76	1.06	1.76	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	1.41	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.33	1.84	1.38	0.00	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.18	1.93	1.29	0.32	0.96	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	55.18	2.07	2.41	0.69	1.72	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	596.71	7.59	5.06	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	46.56	5.35	2.67	0.89	1.56	0.45	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.47	1.27	0.85	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.65	0.47	1.66	0.95	0.24	0.47	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	2.58	1.29	0.86	0.43	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	297.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	29.99	1.67	1.33	0.67	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.50	5.86	6.76	3.16	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	0.00	1.19	0.79	0.40	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	0.93	0.00	0.00	0.93	0.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	1.89	1.51	0.38	0.00	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	1.63	0.65	0.33	0.00	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	41.40	1.31	2.18	0.87	1.31	0.87	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	56.99	4.52	4.52	0.00	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	2.65	1.76	0.88	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	0.66	3.32	0.00	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	1.98	0.00	0.50	0.00	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.88	3.45	1.53	1.15	0.38	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.01	0.91	0.00	1.21	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	43.98	4.86	1.77	1.11	1.33	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	2.71	2.71	3.39	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	245.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	1.22	2.44	0.00	0.00	1.22	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.37	3.15	2.52	0.31	0.31	1.26	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	33.29	2.12	1.51	0.91	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	1.58	2.37	1.58	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	98.63	1.13	1.13	0.00	1.13	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	146.68	0.00	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	11.06	2.11	0.62	0.37	0.50	0.50	0.00	0.00
Myoblast, donor2	11322-117D8	33.18	3.64	1.53	0.96	0.77	0.38	0.00	0.00
Myoblast, donor3	11398-118D3	20.85	2.69	1.85	0.50	0.67	0.00	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	43.63	21.31	4.09	2.04	0.58	0.58	2.33	0.73
Natural Killer Cells, donor1	11230-116C6	47.05	22.45	4.92	3.38	2.77	0.92	2.77	0.92
Natural Killer Cells, donor2	11311-117C6	56.69	26.54	4.52	3.92	2.11	0.90	3.62	0.30
Natural Killer Cells, donor3	11387-118C1	62.39	24.30	4.79	3.68	2.02	0.37	2.94	0.92
Neural stem cells, donor1	11275-116H6	67.14	14.52	10.16	5.81	11.98	1.45	2.90	3.63
Neural stem cells, donor2	11352-117H2	90.51	28.88	15.41	7.70	13.48	3.85	1.93	1.93
Neurons, donor1	11494-119E9	47.79	23.90	2.28	7.97	12.52	1.14	2.28	0.00
Neurons, donor2	11574-120E8	53.94	10.35	4.84	4.62	6.16	1.10	1.32	0.00
Neurons, donor3	11655-122E8	37.00	11.51	13.15	7.40	10.69	3.29	4.11	0.82
Neutrophils, donor1	11233-116C9	96.51	12.06	0.93	3.71	3.71	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	98.56	26.09	0.00	2.90	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	122.78	15.88	3.05	6.11	9.77	0.00	3.05	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	45.24	1.07	1.07	0.47	1.19	0.36	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	36.79	2.93	0.65	0.00	0.33	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	19.85	2.01	1.80	0.60	0.40	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	17.76	1.65	0.55	0.28	0.41	0.41	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	20.55	2.32	1.88	0.14	0.14	0.58	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	18.73	1.59	0.79	0.57	0.45	0.57	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	38.57	2.53	1.17	1.46	0.39	0.68	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	22.87	1.81	1.20	3.61	0.60	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	16.80	1.91	1.06	0.43	0.64	0.21	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	11.43	1.14	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	24.21	0.62	0.62	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	11.53	2.54	1.56	0.59	0.59	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	27.39	7.02	3.51	1.40	0.70	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	22.75	5.51	2.84	1.07	1.07	1.07	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	26.70	4.46	2.61	1.01	0.67	0.67	0.17	0.59
Pericytes, donor1	11491-119E6	13.02	1.34	0.78	0.33	0.45	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	19.47	1.13	0.45	0.23	0.00	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	13.83	2.03	0.61	0.41	0.00	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	23.51	2.49	1.58	1.13	0.57	0.45	0.23	0.00
Perineurial Cells, donor2	11579-120F4	26.59	3.50	1.56	1.29	1.20	0.64	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	56.10	12.75	4.14	3.19	2.55	1.27	1.27	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	53.87	10.04	1.96	4.41	0.73	0.00	0.98	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	67.81	14.75	4.14	2.98	1.68	0.78	1.04	0.13
Placental Epithelial Cells, donor1	11278-116H9	6.46	1.91	0.96	0.96	0.48	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	1.11	0.00	0.00	0.00	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	19.44	2.36	0.79	0.39	0.59	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.13	0.63	0.32	0.63	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	11.07	1.13	0.19	0.00	0.75	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.84	1.04	1.31	0.65	0.39	0.13	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	18.24	0.68	0.90	0.45	0.90	0.45	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	15.02	1.28	0.43	0.43	0.64	0.11	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	13.97	2.18	0.87	0.00	0.44	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	16.19	2.72	0.57	0.72	0.14	0.29	0.72	0.57
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.14	2.46	0.92	0.61	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.56	6.55	3.19	1.42	0.71	0.89	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	22.31	2.38	2.55	0.51	0.85	0.34	0.17	0.68
Preadipocyte - visceral, donor1	11280-116I2	27.20	4.75	2.51	1.21	1.30	1.68	0.19	0.65
Preadipocyte - visceral, donor2	11357-117H7	28.99	5.06	3.22	1.84	1.38	1.84	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	21.84	3.34	2.51	1.25	0.84	0.84	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	55.66	15.84	6.18	4.98	5.43	0.75	0.45	2.41
Prostate Epithelial Cells, donor2	11331-117E8	17.47	3.79	2.30	0.95	0.14	0.54	0.41	0.27
Prostate Epithelial Cells, donor3	11404-118D9	31.97	1.47	0.92	0.67	1.16	0.37	0.06	0.55
Prostate Stromal Cells, donor1	11254-116F3	14.69	3.42	1.59	0.46	0.57	0.46	0.46	0.00
Prostate Stromal Cells, donor2	11332-117E9	19.90	4.66	2.15	1.61	0.90	1.08	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	16.16	2.82	1.46	0.31	0.73	0.52	0.00	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	2.92	1.46	0.36	0.73	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.78	2.56	0.90	0.90	0.35	0.55	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	15.72	2.03	1.52	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	11.38	1.42	0.71	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	20.22	4.02	1.06	0.85	0.74	0.74	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	2.04	0.68	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.92	2.83	1.21	0.54	0.13	0.67	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	33.75	7.55	1.55	3.55	0.22	0.89	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	0.67	1.33	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.53	3.30	1.10	1.10	1.10	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	18.81	2.51	1.88	1.88	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.32	0.55	0.55	0.00	0.83	0.00	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.69	3.76	1.61	0.54	0.81	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.49	2.11	0.42	0.42	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	22.76	1.93	0.77	0.77	1.16	0.39	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.30	2.33	0.52	0.78	0.52	0.78	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.74	2.84	0.00	0.57	0.57	0.28	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	0.00	2.06	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.32	5.02	0.50	1.51	0.75	0.25	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	47.71	3.74	2.14	1.60	2.27	0.80	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	65.22	11.61	4.47	0.89	3.57	0.00	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	86.41	9.36	1.65	2.20	3.85	0.00	0.00	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	103.25	13.92	5.22	2.32	4.06	0.58	0.00	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	94.40	10.27	3.38	3.38	2.21	0.78	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	83.81	9.53	3.18	2.98	1.79	1.49	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	57.33	8.37	2.68	2.79	2.01	1.12	0.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	92.54	9.43	3.60	2.60	1.49	0.87	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	83.45	7.34	1.75	1.86	1.98	0.93	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	109.33	10.86	2.31	2.54	3.24	1.39	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	114.59	13.01	4.52	3.15	1.37	0.41	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	93.79	11.19	3.33	2.12	2.42	0.91	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	65.58	8.78	3.05	1.79	2.15	0.36	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	90.52	9.04	2.87	3.87	0.86	0.43	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	79.73	8.59	2.79	1.93	1.82	0.64	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	87.18	9.07	2.88	2.43	1.33	0.22	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	119.29	12.81	3.82	3.25	2.10	0.96	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	103.88	10.53	2.70	3.26	1.86	0.93	0.28	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	72.53	11.46	2.44	4.70	2.44	1.50	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	139.87	16.46	3.72	2.65	2.79	1.19	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	103.86	8.86	3.80	3.80	1.95	1.27	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	90.71	10.12	3.44	2.67	1.91	0.95	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	106.90	9.18	4.49	2.14	1.82	1.39	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	84.65	8.13	3.08	2.24	5.05	1.12	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	107.15	10.60	3.42	3.08	2.91	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	124.17	10.39	4.01	3.28	1.82	1.09	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	93.20	9.07	2.70	1.96	2.08	0.98	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	95.64	8.19	3.63	2.69	1.75	1.75	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	89.16	9.20	3.77	1.89	0.47	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	93.45	9.52	3.77	2.18	1.79	0.79	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	83.48	10.52	4.21	2.10	2.10	1.17	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	93.93	8.71	3.53	1.66	1.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	85.83	11.28	4.65	2.43	2.43	1.33	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	91.91	9.40	3.34	2.09	2.09	1.88	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	110.90	13.32	3.63	2.29	1.62	0.94	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	136.41	13.45	4.26	3.58	3.07	0.85	1.02	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	105.46	16.19	5.01	3.08	4.05	0.77	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	109.35	13.58	3.27	2.92	1.72	1.03	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	112.48	15.36	5.08	1.78	2.33	1.10	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	108.84	9.36	3.45	3.12	2.63	0.82	0.99	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	117.43	9.20	4.77	3.24	2.22	1.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	107.71	9.77	3.40	2.22	3.26	1.48	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	109.02	11.20	2.40	3.73	2.40	1.60	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	125.41	14.93	3.18	3.32	2.77	0.69	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	97.38	6.43	2.62	2.62	1.90	2.14	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	190.05	16.93	2.82	6.45	3.83	0.81	0.81	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	91.16	6.59	2.83	2.17	2.26	0.47	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	100.97	10.48	4.89	5.94	4.54	1.40	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	109.70	12.69	3.32	4.53	3.02	1.21	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	92.89	9.67	3.43	2.57	2.94	0.24	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	141.62	19.21	3.64	4.51	6.11	1.31	1.16	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	86.40	9.73	4.87	4.87	3.04	1.22	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	90.72	10.55	1.81	3.62	2.11	0.90	0.90	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	94.77	12.67	2.71	6.11	5.43	1.36	0.23	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	116.52	10.78	1.80	5.09	4.49	2.10	0.90	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	69.19	8.38	6.02	1.42	7.08	0.59	0.12	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	91.14	9.61	6.83	4.91	6.62	1.49	0.21	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	85.94	16.23	3.61	6.61	3.61	1.20	0.60	3.61
Schwann Cells, donor1	11498-119F4	19.75	2.44	1.69	0.38	0.56	0.56	0.19	0.00
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.69	6.35	0.66	1.97	0.44	0.44	0.00	0.00
Sebocyte, donor1	11220-116B5	42.18	11.50	4.38	1.10	0.55	0.55	0.55	0.55
Sebocyte, donor2	11301-117B5	27.57	5.51	3.68	1.38	2.30	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	26.38	2.27	1.24	1.03	1.03	0.41	0.21	0.21
Sertoli Cells, donor1	11255-116F4	18.22	0.00	1.66	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.65	4.84	1.41	0.97	2.29	0.44	0.09	0.97
Skeletal Muscle Cells, donor2	11358-117H8	9.40	0.00	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	24.25	6.69	2.51	4.18	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.81	6.60	2.20	2.83	1.26	0.00	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	21.26	4.46	1.49	1.78	1.49	1.19	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	23.09	5.69	2.15	2.62	1.08	0.77	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.77	4.28	2.77	1.51	1.26	0.63	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.39	4.00	2.00	2.43	1.57	0.86	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	31.95	6.55	3.67	3.08	1.88	1.09	0.79	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.34	3.29	2.61	0.76	1.01	0.42	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	2.90	2.17	2.17	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.69	3.16	1.51	0.55	0.69	0.41	0.14	0.00
Skin - palm, donor1	10286-104F7	34.92	8.06	0.00	0.00	5.37	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	18.74	2.45	2.02	1.30	0.58	0.29	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	59.71	4.91	2.45	2.45	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.02	3.38	0.26	0.52	0.91	0.00	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	16.96	2.09	1.53	0.56	0.56	0.28	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	33.05	8.30	3.52	1.83	1.69	0.70	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	58.36	11.00	2.96	4.02	1.48	0.63	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	43.02	4.72	2.92	2.32	1.72	1.20	0.37	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	19.44	3.09	1.54	0.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.79	3.56	1.56	1.11	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	2.94	0.59	0.59	0.59	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.35	2.65	2.43	1.33	0.88	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	2.36	1.97	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	2.32	0.00	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	3.00	3.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	12.24	1.20	1.20	0.13	0.27	0.27	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.62	1.33	1.33	0.66	0.44	0.66	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.86	1.54	1.02	1.02	0.26	0.51	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	15.95	3.26	0.98	0.33	0.65	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	20.38	2.95	0.89	0.59	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.08	3.70	0.71	0.85	0.14	0.28	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.78	0.65	0.98	0.65	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	50.54	3.04	2.44	0.91	0.61	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	17.43	1.26	2.02	0.76	0.51	0.25	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	110.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.58	0.48	0.00	0.00	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.22	2.65	1.03	1.18	0.15	0.29	0.00	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.46	3.01	1.51	1.08	0.43	0.65	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	21.73	3.88	1.26	1.05	0.73	0.31	0.21	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.89	2.01	0.93	0.31	0.46	0.62	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	5.39	0.00	0.00	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.56	2.69	1.49	1.20	0.00	0.90	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.02	2.05	1.71	0.68	0.34	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.64	2.20	0.94	0.79	0.39	0.31	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	29.19	2.31	1.11	1.11	1.71	0.40	0.30	1.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	21.39	3.87	1.14	0.91	0.46	0.23	0.00	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	0.60	0.60	0.00	0.00	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.08	8.21	2.91	3.44	2.12	0.26	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	18.91	3.33	3.06	0.67	0.53	0.53	0.27	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	23.04	3.63	2.75	1.13	1.75	0.63	0.38	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.94	0.76	0.76	0.25	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.04	1.66	1.66	1.06	0.75	0.45	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	2.25	0.75	0.00	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	98.21	20.68	16.80	5.17	5.17	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.88	3.72	3.26	0.47	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.13	1.01	1.51	1.01	0.50	0.00	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	2.19	1.25	1.25	0.63	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	2.36	1.18	0.29	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.33	9.83	3.83	4.25	1.58	1.00	0.50	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	2.34	2.34	1.87	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.19	1.30	0.72	0.00	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.32	2.29	0.76	0.76	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.40	3.01	1.13	0.56	0.38	0.19	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	31.02	4.75	1.12	2.10	1.12	0.70	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.33	2.26	0.75	0.92	0.42	0.08	0.42	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.86	0.95	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.74	0.49	0.73	0.24	0.24	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.91	2.43	2.65	0.66	0.00	0.66	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.00	0.88	0.59	0.29	0.00	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.60	2.53	1.17	0.97	1.55	0.58	0.00	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.34	2.64	0.79	0.53	0.53	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.11	1.49	0.74	0.37	0.37	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	2.52	1.80	0.36	0.36	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.48	2.84	1.99	0.00	0.28	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.39	3.54	0.39	0.00	1.58	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	17.78	1.52	1.27	0.51	0.00	0.51	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	36.34	3.59	1.60	0.40	0.40	0.00	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	0.84	0.42	0.42	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	1.83	0.92	0.92	0.92	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	15.15	2.02	1.18	0.50	0.34	0.34	0.00	0.17
Synoviocyte, donor2	11368-117I9	20.95	1.34	0.84	0.34	0.84	0.34	0.00	0.67
Synoviocyte, donor3	11440-118H9	20.78	0.67	0.89	0.22	0.45	0.22	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	23.23	4.65	2.50	1.07	0.00	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	1.98	1.98	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	27.79	7.18	1.39	2.08	1.16	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	13.55	3.87	1.36	0.86	0.36	0.50	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	13.92	1.55	1.55	0.39	0.39	1.16	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	2.29	0.57	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	46.38	5.29	1.60	2.21	2.58	0.37	0.37	0.49
Urethra, donor2	10319-105A4	86.32	12.59	1.80	1.80	5.40	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.10	2.13	1.06	0.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	12.82	0.80	0.00	0.80	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	14.90	1.60	1.38	0.46	0.23	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	30.76	2.23	1.56	0.67	0.22	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	6.23	7.12	3.56	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	1.43	2.86	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	45.86	3.42	1.37	2.74	0.00	0.68	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	47.17	5.17	2.75	4.13	2.07	0.00	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.60	5.23	2.32	3.49	0.58	0.00	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	41.65	9.37	1.04	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	41.30	7.34	0.00	0.00	0.00	0.00	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	45.64	8.22	0.00	4.56	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	24.67	20.48	6.17	4.81	2.84	0.86	1.85	0.25
Wilms' tumor cell line:HFWT	10597-108E3	56.32	20.24	8.80	7.04	2.64	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	57.82	9.50	3.35	2.79	1.40	1.96	0.84	0.28
achilles tendon, donor2	10292-104G4	43.40	2.07	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	37.73	14.28	1.53	1.27	1.53	0.25	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	50.85	11.61	3.48	2.55	4.64	0.93	1.16	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	80.48	12.46	2.85	4.04	2.14	0.71	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	18.50	7.35	4.63	3.54	1.36	1.09	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	46.66	10.96	3.09	2.25	3.09	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.82	3.38	1.06	0.63	1.06	0.42	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	41.38	4.36	1.63	1.36	0.82	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	39.22	6.17	1.76	0.88	1.32	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	41.65	3.27	3.68	0.82	1.23	0.82	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	35.34	9.71	7.77	2.72	2.33	1.55	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	39.19	4.42	2.76	1.47	1.66	0.37	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	7.80	11.70	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	14.64	9.76	3.72	2.32	1.39	1.16	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	53.85	9.32	5.70	1.55	0.78	0.78	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	56.40	4.09	3.51	1.75	2.63	1.46	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	91.56	4.65	3.25	0.46	1.39	0.00	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	43.59	5.76	1.23	1.23	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	42.67	10.13	4.30	0.92	2.46	0.00	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	54.62	3.84	2.13	0.85	1.71	0.43	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	51.86	6.37	1.82	1.52	1.52	0.30	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	57.53	6.02	1.44	1.93	1.20	1.20	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	41.21	5.35	2.45	1.34	1.34	0.22	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	87.72	7.34	2.67	3.00	0.67	1.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	172.81	5.57	11.15	9.29	3.72	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	51.98	5.27	1.51	2.26	0.38	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	88.53	23.12	12.65	3.93	4.36	2.62	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	129.34	15.00	11.25	9.37	1.87	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	71.12	7.77	3.30	0.71	1.18	0.71	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	33.97	3.26	1.86	1.09	2.64	0.00	0.16	0.16
adipose, donor1	10184-103D4	99.10	11.73	2.35	8.21	13.49	0.00	0.59	12.31
adipose, donor2	10185-103D5	74.62	23.52	3.24	9.33	11.76	0.00	0.81	2.03
adipose, donor3	10186-103D6	75.42	16.34	3.81	10.07	11.16	0.27	1.36	0.82
adipose, donor4	10187-103D7	185.48	23.40	5.20	7.80	7.80	0.87	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	80.49	20.67	6.00	4.89	2.37	0.16	1.89	0.16
adrenal gland, adult, pool1	10081-102A9	50.93	14.55	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	29.88	4.80	1.47	0.13	0.67	0.13	1.33	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.80	10.00	7.50	1.07	2.14	1.07	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	50.08	2.78	1.62	0.23	1.62	0.70	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	50.38	1.01	1.01	0.34	1.01	1.01	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	70.12	1.18	1.18	1.18	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	52.18	11.86	5.93	2.37	3.56	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	96.11	16.22	9.94	6.49	2.64	2.43	1.42	0.00
amygdala, newborn, donor10223	10360-105E9	40.67	8.39	6.46	2.26	2.58	0.97	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	55.13	2.80	1.40	0.64	1.27	0.51	0.13	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	35.74	13.02	2.65	3.31	0.44	0.22	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	111.90	34.74	12.36	7.01	4.34	0.67	1.00	0.33
aorta, adult, pool1	10052-101G7	65.51	3.14	1.96	1.57	0.59	0.39	0.39	0.39
appendix, adult	10189-103D9	72.58	22.90	5.43	4.27	4.27	1.16	2.33	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	88.39	3.78	1.72	1.38	2.75	0.69	0.34	0.69
artery, adult	10190-103E1	46.20	10.87	2.72	1.36	2.72	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.02	2.75	0.58	1.16	0.87	0.29	0.00	0.00
b cell line:RPMI1788	10427-106D4	50.11	19.18	2.08	1.34	2.53	0.30	2.38	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	10.82	0.83	1.66	0.55	0.55	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	35.23	9.63	2.28	1.29	1.69	0.79	0.69	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	56.57	8.03	2.34	1.00	0.84	0.67	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.03	5.03	4.47	2.80	1.68	0.00	1.12	0.00
bladder, adult, pool1	10011-101C2	69.42	4.24	1.52	1.63	1.63	0.54	0.33	0.76
blood, adult, pool1	10053-101G8	35.43	11.07	2.21	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.10	5.14	3.43	0.86	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	41.16	6.75	2.70	0.67	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	32.80	5.13	5.13	5.13	4.10	4.10	1.03	0.00
brain, adult, pool1	10012-101C3	53.56	6.79	3.79	2.78	4.01	1.67	1.45	0.45
brain, fetal, pool1	10085-102B4	82.81	16.03	2.67	10.69	8.01	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	128.51	13.54	9.58	3.63	3.96	1.65	2.97	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	155.03	9.86	3.74	1.62	1.25	0.87	1.12	0.37
breast, adult, donor1	10080-102A8	60.61	7.58	3.79	3.16	2.53	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	44.34	8.77	4.83	2.54	1.14	1.91	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	63.70	16.39	5.88	6.49	3.71	2.16	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.57	3.22	1.38	0.69	1.38	0.00	0.69	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	80.61	9.20	4.60	2.66	2.18	1.45	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	54.54	4.70	1.41	0.94	2.35	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	119.44	12.69	6.02	4.05	3.72	1.42	0.77	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	42.15	10.77	1.90	1.58	0.95	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	102.74	13.58	5.59	3.99	3.19	0.27	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	71.38	12.66	5.76	1.15	3.45	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	74.79	12.38	6.02	3.51	2.68	1.67	1.51	0.00
caudate nucleus, adult, donor10258	10379-105H1	31.33	6.88	7.64	0.00	0.76	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	39.19	10.25	3.30	2.20	3.30	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	198.10	11.65	2.91	8.74	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	208.17	17.93	7.47	10.89	5.98	2.99	2.78	0.64
cerebellum, adult, pool1	10083-102B2	55.54	6.90	3.79	3.79	3.79	1.03	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	102.13	17.44	10.79	3.32	3.32	0.00	3.32	0.00
cerebral meninges, adult	10188-103D8	41.35	6.56	5.04	3.53	3.53	1.01	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	21.20	4.39	0.73	1.46	2.19	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	21.42	5.46	3.16	1.44	0.00	0.58	0.43	0.14
cervical cancer cell line:ME-180	10553-107I4	33.47	7.29	2.65	2.82	1.16	0.99	0.66	0.00
cervix, adult, pool1	10013-101C4	74.86	8.92	3.78	3.46	3.25	0.94	1.05	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.61	7.11	3.62	2.37	1.53	1.53	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	35.27	2.61	5.23	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	46.98	6.96	1.12	2.73	3.98	0.25	0.37	1.12
choriocarcinoma cell line:SCH	10785-110H2	44.36	7.64	0.99	1.72	0.86	0.25	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	77.32	22.53	0.95	3.08	4.74	0.24	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	29.35	2.85	1.14	1.71	0.28	0.28	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	33.81	2.78	1.19	1.29	1.59	0.50	0.30	0.89
chorionic membrane cells, donor3	12240-129G8	58.25	4.40	1.65	2.20	1.10	0.55	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	4.04	4.04	1.01	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	30.54	5.96	3.27	1.73	1.34	0.00	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.85	9.29	2.96	2.32	0.84	0.84	0.84	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	54.96	11.04	2.57	5.39	1.28	0.00	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	63.37	12.82	5.56	3.14	3.87	0.00	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	60.88	10.99	4.48	3.26	3.26	0.20	0.81	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	24.15	7.66	2.94	2.94	1.47	0.00	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	56.56	13.55	4.17	3.91	3.13	1.56	1.30	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	21.72	5.03	1.37	1.60	0.91	0.69	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	52.05	4.68	2.78	1.91	0.17	0.69	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	48.14	13.91	5.86	4.21	3.48	2.20	1.10	0.18
colon carcinoma cell line:COLO-320	10420-106C6	141.77	7.22	2.66	2.28	2.28	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	42.84	5.95	1.19	0.00	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	51.94	4.58	3.53	1.76	2.82	0.47	0.59	2.12
colon, fetal, donor1	10070-101I7	58.09	8.65	3.71	4.33	7.42	1.24	0.62	2.47
common myeloid progenitor CMP, donor1	12130-128D6	197.09	110.00	36.67	36.67	13.75	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	16.15	14.87	3.40	2.12	1.27	0.85	2.12	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.57	16.60	3.32	2.11	3.47	1.21	2.72	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	8.60	14.24	6.49	1.27	1.41	1.13	1.69	0.42
corpus callosum, adult, pool1	10042-101F6	75.07	11.83	2.76	5.31	5.31	1.22	1.11	0.77
cruciate ligament, donor2	10295-104G7	44.58	3.24	1.62	0.00	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	41.73	7.22	3.21	2.41	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	41.04	7.92	2.64	4.32	3.12	1.44	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	51.66	19.75	2.98	3.67	1.84	0.69	1.38	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	39.49	16.41	9.74	4.62	3.59	3.85	1.03	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.18	8.43	1.44	1.69	1.69	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	99.67	4.98	1.50	1.99	2.99	1.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	48.97	4.32	0.00	1.44	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	60.32	10.30	5.15	2.94	2.21	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	70.94	4.05	2.40	2.31	0.83	1.16	0.50	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	28.20	33.09	5.11	6.66	4.44	2.44	2.22	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	25.51	15.76	2.15	3.44	2.58	1.15	0.29	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	50.56	12.33	2.47	0.62	0.62	0.00	2.47	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	50.25	2.72	1.82	0.91	1.82	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.44	11.42	2.47	0.93	1.23	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	86.69	17.08	1.31	1.31	1.31	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	50.28	13.41	3.69	5.36	2.35	1.34	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	39.15	4.53	0.91	0.91	1.63	0.54	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.85	2.09	0.80	0.32	0.16	0.32	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	63.69	18.12	6.34	4.00	2.78	1.89	1.78	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	68.30	19.80	4.07	2.64	1.76	1.43	1.21	0.44
epididymis, adult	10197-103E8	71.17	5.02	2.51	1.47	6.28	0.84	0.84	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.00	3.19	2.31	1.06	1.24	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.58	6.69	2.75	1.18	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	50.06	4.72	2.75	1.70	0.92	0.39	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	90.55	7.68	3.74	2.26	1.67	1.57	0.69	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	52.32	6.05	3.14	2.02	0.56	0.56	0.34	0.00
esophagus, adult, pool1	10015-101C6	46.08	3.29	2.65	1.49	2.34	0.96	0.85	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	79.78	18.16	5.13	7.14	5.26	1.00	1.00	1.00
eye - muscle inferior rectus, donor1	10272-104E2	19.32	2.41	2.41	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	44.19	2.10	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	1.49	0.00	0.00	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	25.22	4.59	0.00	0.00	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	4.37	0.00	4.37	4.37	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	53.39	6.86	1.53	3.56	1.78	0.76	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	12.44	6.54	1.67	1.92	1.15	0.00	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	52.71	18.76	5.46	3.56	3.09	1.19	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	54.89	8.44	4.41	3.38	3.66	1.13	1.78	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	94.88	14.41	3.60	4.80	3.00	0.60	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	49.10	13.44	4.48	1.01	3.29	0.55	1.19	0.00
gall bladder, adult	10198-103E9	64.70	6.76	3.86	0.97	2.41	1.21	0.48	0.97
gamma delta positive T cells, donor1	11937-126A2	43.49	9.13	3.22	2.68	0.00	0.54	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	39.22	10.46	2.99	2.99	1.87	0.37	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.12	9.93	3.38	2.53	1.27	2.75	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	52.80	11.60	6.19	3.48	1.93	1.35	0.97	0.39
gastric cancer cell line:AZ521	10549-107H9	32.14	11.48	4.59	2.79	4.59	0.98	1.15	0.00
gastric cancer cell line:GSS	10560-108A2	51.25	3.66	4.58	1.83	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	91.61	17.59	2.74	7.08	6.63	0.69	0.91	2.28
giant cell carcinoma cell line:LU65	10487-107B1	14.00	2.64	0.57	0.80	0.69	0.11	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	74.18	5.18	2.10	1.96	1.40	0.84	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	76.32	14.72	6.73	2.99	2.99	0.75	0.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.68	4.64	3.91	1.16	1.58	0.84	0.42	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	51.68	5.48	3.93	1.40	1.40	0.56	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	27.59	4.86	4.19	1.21	2.21	1.32	0.66	0.00
glioma cell line:GI-1	10413-106B8	77.61	5.27	4.10	3.22	2.05	0.88	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	49.57	9.48	3.64	3.64	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	108.13	11.23	3.42	4.88	3.91	1.22	2.20	0.00
globus pallidus, adult, donor10258	10367-105F7	26.01	5.48	2.74	0.00	2.74	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	26.65	6.93	2.13	2.13	1.60	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	210.45	78.31	19.58	17.13	12.24	2.45	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	35.84	6.72	1.28	0.96	0.64	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	45.45	21.58	4.59	6.89	2.30	0.46	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	42.98	22.41	5.49	5.94	1.83	0.00	0.91	0.46
hIPS +CCl2, biol_rep3	14385-156C2	35.43	25.12	4.51	2.58	1.93	0.00	0.00	3.22
hIPS, biol_rep1	14380-156B6	40.24	30.18	4.31	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	41.84	16.46	3.43	2.74	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	44.14	7.72	5.52	0.00	2.21	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	39.37	12.93	1.72	1.44	1.44	0.29	0.86	0.00
heart - mitral valve, adult	10205-103F7	50.23	5.38	2.69	0.60	1.20	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	69.81	6.54	2.88	2.35	2.35	0.78	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	57.45	6.66	5.00	1.67	1.67	0.00	0.83	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	41.42	4.90	1.63	1.02	1.63	0.61	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	31.09	5.54	0.85	2.55	0.85	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	23.69	4.37	0.23	0.23	1.38	1.15	0.69	0.00
heart, fetal, pool1	10046-101G1	70.44	6.67	3.49	2.16	3.18	0.62	1.03	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.38	2.47	0.93	0.00	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	68.97	26.16	9.51	3.57	7.14	0.00	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	78.78	10.72	4.31	5.97	4.64	1.22	0.88	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.62	9.35	4.61	6.80	3.16	0.61	0.97	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	94.48	12.03	3.44	5.36	3.13	1.11	0.71	0.10
hepatoma cell line:Li-7	10484-107A7	24.80	4.78	1.33	2.34	0.44	0.67	0.22	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	30.25	13.47	1.41	2.01	1.01	0.10	0.60	0.00
hippocampus - adult, donor10196	10169-103B7	58.67	8.52	4.73	1.89	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	96.54	14.49	6.33	4.49	4.49	1.22	2.04	0.41
hippocampus, adult, donor10258	10374-105G5	33.36	3.98	6.47	2.49	1.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	31.37	16.92	8.11	1.76	5.64	0.70	2.11	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	32.35	14.04	3.66	4.88	3.05	0.00	0.61	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	35.74	23.56	3.14	6.28	2.95	0.59	0.98	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.62	19.04	3.55	2.54	3.81	0.25	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	82.32	32.70	7.89	10.15	12.41	0.00	0.00	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	97.09	29.18	9.04	22.21	18.07	1.29	2.07	7.23
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	58.46	23.92	4.18	8.35	13.67	0.38	0.38	5.31
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	61.60	16.35	4.67	6.71	11.97	1.17	0.00	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	74.97	21.11	4.52	10.13	10.34	0.86	1.08	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	46.30	21.27	5.84	7.51	6.67	0.83	0.00	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.17	14.21	4.26	5.45	3.32	1.18	0.71	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	62.52	18.48	5.63	7.07	8.52	0.96	1.29	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.11	11.45	0.67	4.71	8.08	2.02	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.27	20.81	3.44	5.01	3.91	0.47	0.63	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	40.78	14.74	3.44	5.90	4.42	0.49	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	13.96	1.75	6.11	0.87	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	95.26	37.23	4.77	19.09	19.09	1.15	1.91	7.45
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	93.32	33.58	6.11	14.39	8.29	1.74	0.87	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	88.46	17.99	5.00	10.49	15.49	0.00	0.00	12.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	56.71	11.87	2.07	6.59	4.71	0.57	0.57	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.84	13.19	3.18	8.64	7.28	0.91	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	66.72	12.84	3.13	9.71	5.33	0.31	0.94	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	46.54	14.53	1.63	6.04	3.59	0.49	0.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	43.26	13.35	2.32	4.94	2.90	0.29	0.29	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	62.77	14.05	2.39	5.68	4.48	0.00	0.00	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.87	28.64	3.51	6.47	5.91	0.55	1.29	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	32.52	24.25	3.71	4.56	3.71	0.29	1.43	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	37.16	20.82	4.90	3.67	5.72	1.22	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	80.27	22.89	7.04	10.91	9.51	1.06	0.00	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	61.13	24.71	6.65	13.94	10.45	0.95	1.27	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	64.46	22.70	4.24	8.47	8.78	0.00	0.61	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.20	12.93	1.55	6.21	3.62	0.52	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	45.83	11.29	3.98	2.66	4.65	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	31.30	12.57	2.31	2.82	2.57	1.03	0.51	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.37	10.74	2.56	4.86	2.56	0.77	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	56.03	9.84	3.79	6.06	5.30	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	34.95	13.11	2.69	1.68	2.02	1.01	0.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	46.37	32.36	4.11	9.18	6.04	1.69	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	47.24	29.41	2.23	3.12	8.02	1.78	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	38.54	33.66	2.44	3.41	2.44	0.98	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	79.77	30.26	4.58	15.28	18.03	1.83	1.22	3.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	110.61	19.52	3.25	3.25	3.25	3.25	0.00	32.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	59.57	20.85	4.63	7.28	12.24	0.99	0.66	8.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.99	13.14	3.28	6.57	9.30	0.55	0.00	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	53.20	12.30	1.45	5.07	6.51	0.00	0.72	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.79	12.46	3.20	3.56	3.20	0.00	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	42.96	15.51	2.39	7.16	3.58	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.14	17.06	3.25	7.31	8.26	0.27	0.81	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	41.22	12.66	1.35	3.77	5.66	0.81	0.27	2.16
immature langerhans cells, donor1	11904-125F5	33.90	7.26	1.70	0.48	0.73	0.24	0.24	0.00
immature langerhans cells, donor2	11905-125F6	37.23	3.17	1.58	0.79	0.00	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	57.44	9.37	7.38	3.22	6.06	2.27	1.99	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	28.61	9.10	4.23	3.58	0.98	3.25	0.33	0.65
kidney, adult, pool1	10017-101C8	40.35	5.21	1.20	1.40	2.40	0.80	0.10	0.50
kidney, fetal, pool1	10045-101F9	79.22	7.14	2.83	2.26	2.19	0.92	0.57	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	41.61	12.64	2.70	5.11	2.84	1.28	0.99	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	26.54	2.21	1.24	0.41	0.41	0.41	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	45.32	13.76	1.83	2.57	2.20	0.92	0.37	0.00
left atrium, adult, donor1	10079-102A7	47.40	3.81	2.18	3.81	0.54	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	22.75	4.05	2.02	2.02	0.51	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	40.22	18.33	9.30	4.38	3.56	3.01	1.37	0.27
leiomyoma cell line:10964C	10569-108B2	11.14	1.44	1.44	0.36	0.36	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	11.41	0.00	1.09	1.09	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	17.00	1.46	1.46	0.97	0.49	0.97	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	83.64	6.27	5.23	1.05	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	40.02	21.25	4.13	4.84	1.42	0.59	1.30	0.12
liposarcoma cell line:KMLS-1	10782-110G8	34.99	4.37	2.66	0.78	0.78	0.78	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	52.88	11.09	3.17	3.17	3.17	0.97	1.83	0.12
liver, adult, pool1	10018-101C9	39.54	1.94	2.76	1.46	2.43	0.16	0.00	0.16
liver, fetal, pool1	10086-102B5	31.04	1.88	0.94	3.76	0.00	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	64.31	8.31	3.06	4.23	3.79	0.73	0.73	0.44
locus coeruleus, adult, donor10252	10165-103B3	76.77	9.97	2.03	4.06	3.14	0.18	1.48	0.00
locus coeruleus, adult, donor10258	10375-105G6	21.16	4.51	1.41	2.26	1.13	0.28	1.13	0.00
locus coeruleus, newborn, donor10223	10362-105F2	54.26	7.99	3.36	2.94	4.63	0.42	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	23.80	5.54	1.66	2.21	2.08	0.55	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	137.19	2.07	6.89	1.38	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	58.79	11.86	8.70	4.48	8.04	0.53	2.11	0.00
lung, adult, pool1	10019-101D1	47.84	3.78	1.42	1.42	1.42	0.12	0.59	1.06
lung, fetal, donor1	10068-101I5	84.48	9.13	3.14	2.57	3.42	0.29	1.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	78.81	8.25	6.87	6.87	5.04	0.00	0.00	1.37
lymph node, adult, donor1	10077-102A5	44.97	13.25	3.79	4.73	0.95	0.95	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	34.85	12.71	1.10	1.32	0.88	0.22	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	36.83	12.38	1.51	2.72	0.60	0.60	0.91	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	42.47	25.48	8.49	5.10	4.25	1.70	0.85	0.00
mature adipocyte, donor1	12231-129F8	56.83	3.11	0.89	0.89	0.89	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	41.71	1.25	1.04	0.42	0.42	0.83	0.42	0.00
mature adipocyte, donor3	12233-129G1	36.03	1.66	1.19	1.19	0.95	0.47	0.00	0.24
mature adipocyte, donor4	12234-129G2	38.96	2.63	1.84	1.32	0.53	0.26	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	167.73	11.20	9.29	4.77	7.62	0.95	0.95	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	51.89	5.64	4.51	0.00	2.26	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	103.91	13.79	5.70	5.15	2.76	1.47	1.66	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	35.58	4.45	2.54	1.27	1.27	0.00	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	43.08	5.12	5.97	0.85	5.12	0.85	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	77.12	8.94	8.27	6.24	4.39	1.52	1.18	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	118.42	15.92	6.58	5.94	3.40	1.49	1.70	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	1.93	5.78	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	49.17	12.20	3.59	2.51	4.67	0.36	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	42.83	5.19	1.95	1.95	1.30	0.00	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	102.17	9.29	2.48	3.87	2.79	0.77	0.62	0.31
medulla oblongata, adult, pool1	10038-101F2	52.65	7.84	1.71	2.78	2.04	1.31	1.22	0.00
medulla oblongata, newborn, donor10223	10361-105F1	39.58	4.86	2.08	1.74	1.39	1.04	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	143.92	51.59	5.09	8.86	2.88	0.44	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	55.15	24.94	8.56	6.48	3.42	1.83	1.35	0.37
melanoma cell line:COLO 679	10514-107E1	25.44	11.07	3.16	2.59	1.72	0.72	1.01	0.86
melanoma cell line:G-361	10465-106H6	35.29	5.16	1.36	4.07	2.71	0.54	0.27	1.63
meningioma cell line:HKBMM	10691-109F7	26.77	3.98	1.09	0.72	0.72	0.18	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	100.45	34.37	6.17	5.29	16.74	0.00	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	39.92	10.63	2.59	3.37	2.85	0.78	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.49	2.45	2.15	0.61	0.46	0.61	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.45	2.91	1.27	0.55	0.18	0.91	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	14.49	1.66	0.83	0.83	0.83	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	19.95	0.70	0.70	0.28	0.42	0.42	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.52	0.19	0.96	0.19	0.58	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	23.60	2.78	0.69	0.00	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.33	1.72	0.34	0.51	0.34	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.85	1.04	0.92	0.58	0.12	0.46	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.77	2.25	0.80	0.40	1.06	0.66	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	13.77	3.78	1.76	0.68	0.68	0.68	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	19.49	2.85	1.42	0.28	0.71	0.43	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.42	3.29	1.32	0.66	0.33	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	24.77	2.21	2.35	0.83	1.11	1.11	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.39	0.70	0.70	1.40	0.35	0.70	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.70	0.20	0.41	0.20	0.61	0.00	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	0.72	1.80	0.36	0.72	1.08	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.90	1.34	0.41	0.41	0.31	0.21	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.82	1.82	1.14	0.46	0.23	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.85	6.71	4.62	1.26	1.26	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.32	1.94	0.45	0.45	0.15	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.74	2.19	0.09	0.53	0.18	0.09	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.46	1.10	0.00	0.37	1.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.60	2.29	1.72	0.86	0.86	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.00	2.53	1.68	1.26	0.84	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.38	2.74	1.83	0.46	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.37	2.81	1.28	0.00	0.00	1.02	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.32	1.83	1.57	1.05	0.00	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.10	1.54	2.77	0.62	1.23	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.48	1.65	1.18	0.71	0.24	0.24	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.58	1.02	1.02	0.68	1.02	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	2.36	1.57	0.79	0.79	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	1.39	0.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.32	2.88	1.44	0.29	0.87	0.29	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.74	2.23	0.67	0.67	0.00	0.45	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.15	2.40	0.72	0.96	0.00	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.07	2.20	2.20	0.73	2.93	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.14	0.34	0.67	0.34	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	19.24	2.46	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.90	0.43	1.72	1.29	1.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	0.00	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.09	1.62	1.62	0.32	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	1.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	0.53	0.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	1.64	0.00	0.82	2.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	1.94	0.78	0.39	0.78	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	2.10	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	1.99	1.99	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	2.96	3.56	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	2.44	4.87	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	2.53	1.90	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	1.72	1.03	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.82	0.81	0.41	0.00	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	17.48	0.79	0.79	0.00	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	1.77	0.00	1.18	0.59	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.22	1.25	1.87	0.31	0.31	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	0.00	2.67	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	2.37	2.37	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	2.57	0.00	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	2.75	1.38	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	21.77	1.98	0.49	1.48	0.00	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	1.12	1.12	2.24	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	0.64	0.00	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.31	1.61	0.40	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	0.00	0.00	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	1.27	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	25.49	1.82	0.00	0.00	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	1.65	0.82	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.51	1.59	0.60	0.20	0.20	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.71	0.00	1.95	0.32	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	1.02	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	79.69	5.42	0.00	0.00	0.77	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.50	1.65	0.71	0.94	0.47	0.00	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	38.92	9.04	5.56	1.62	1.16	1.16	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	21.37	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.78	4.32	1.85	1.03	0.51	0.21	0.41	0.31
mesothelioma cell line:Mero-25	10850-111F4	37.90	16.34	2.27	0.91	0.91	0.91	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	35.94	7.09	5.87	1.22	0.49	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	25.24	4.65	1.55	0.44	1.11	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	41.00	14.72	4.47	2.89	2.63	0.53	1.84	0.26
mesothelioma cell line:Mero-83	10854-111F8	30.64	7.32	2.04	1.19	0.34	1.19	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	17.44	4.80	3.54	1.01	1.01	2.27	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	29.61	7.25	4.76	1.04	0.62	1.24	0.41	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	26.17	9.11	2.98	1.82	1.66	1.16	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	8.69	8.51	2.90	0.54	0.90	1.09	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	28.36	3.25	1.71	0.68	0.51	0.85	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	59.80	4.33	1.02	0.76	0.76	0.25	0.51	0.25
mesothelioma cell line:No36	10857-111G2	35.88	7.18	4.57	1.63	0.98	1.30	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	27.91	4.06	0.81	0.81	0.81	0.81	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	9.02	13.82	3.07	1.92	0.96	0.19	1.34	0.00
migratory langerhans cells, donor2	11902-125F3	9.40	11.97	3.79	1.47	0.24	0.61	0.85	0.00
migratory langerhans cells, donor3	11903-125F4	13.46	16.15	1.79	1.44	0.36	0.36	1.26	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	48.65	0.98	0.98	2.61	0.00	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.17	4.87	1.27	1.27	0.42	0.00	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	140.98	43.31	12.67	9.91	4.15	4.15	0.69	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	22.07	15.41	3.62	2.47	0.57	0.76	0.76	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.06	4.44	4.62	1.48	0.37	0.92	0.55	0.18
myeloma cell line:PCM6	10474-106I6	15.02	3.56	1.19	1.78	0.40	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	59.35	14.20	3.04	2.03	2.03	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	69.83	7.65	1.57	0.78	0.39	0.98	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.05	0.89	0.22	0.56	0.11	0.56	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	16.03	0.66	0.29	0.51	0.29	0.15	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	66.24	2.21	0.00	0.00	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	113.19	48.08	14.72	23.47	21.86	2.07	2.76	0.00
neuroblastoma cell line:NB-1	10539-107G8	98.78	20.77	5.05	8.61	2.62	1.68	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	58.21	6.12	2.32	1.05	1.69	0.42	0.00	0.63
neuroblastoma cell line:NH-12	10555-107I6	127.65	24.78	4.85	7.83	2.98	0.37	2.05	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	130.00	15.42	4.27	3.32	2.37	0.47	0.47	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	106.27	18.85	6.97	6.97	5.54	1.74	0.63	3.01
neuroectodermal tumor cell line:TASK1	10774-110F9	26.77	6.04	0.81	1.81	1.01	0.60	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	81.38	28.61	6.99	5.09	3.18	4.45	3.81	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	5.32	1.06	0.80	0.80	0.80	1.06	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	135.80	20.63	3.21	8.96	3.04	1.01	2.20	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	50.43	9.61	4.00	5.60	4.00	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.16	4.81	1.60	0.96	0.64	1.92	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.34	3.15	1.31	0.26	0.79	1.05	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	52.21	9.28	5.53	3.28	4.87	2.16	1.87	0.66
occipital cortex - adult, donor10196	10172-103C1	117.44	4.12	6.18	10.30	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	140.09	12.61	5.64	5.64	4.83	2.68	3.22	0.27
occipital cortex, newborn, donor10223	10355-105E4	44.04	14.19	7.28	2.55	4.00	1.82	0.73	1.09
occipital lobe, adult, donor1	10076-102A4	55.37	9.97	6.30	6.56	6.30	2.10	1.05	2.36
occipital lobe, fetal, donor1	10073-102A1	154.91	30.04	18.88	15.88	16.31	3.43	2.57	2.15
occipital pole, adult, pool1	10036-101E9	47.46	6.54	4.26	3.39	3.15	1.02	0.71	0.16
olfactory region, adult	10195-103E6	66.30	10.89	5.35	5.54	3.06	0.76	0.96	0.19
optic nerve, donor1	10277-104E7	108.06	6.00	4.00	2.00	8.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	65.72	8.43	4.67	1.71	3.08	1.94	0.46	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	42.18	7.14	1.37	1.79	1.79	0.82	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.26	8.13	2.71	4.57	2.03	1.86	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	40.08	20.33	7.97	3.12	2.54	0.23	1.27	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	33.51	1.18	0.88	1.18	1.18	0.29	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	68.21	14.95	4.67	3.74	1.87	2.80	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	39.02	5.09	1.91	0.85	0.64	0.64	0.00	1.06
ovary, adult, pool1	10020-101D2	64.55	10.92	3.32	4.11	3.14	0.61	1.31	1.31
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	32.08	11.00	2.93	1.83	1.10	0.55	1.28	0.18
pancreas, adult, donor1	10049-101G4	43.27	5.64	1.88	3.76	0.94	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.92	13.98	3.35	5.03	1.96	0.56	1.12	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	37.48	4.60	1.02	1.53	0.34	0.51	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.60	9.77	2.48	2.48	2.48	0.99	0.17	0.50
paracentral gyrus, adult, pool1	10035-101E8	46.68	6.04	4.94	3.02	3.75	1.01	1.65	0.64
parietal cortex, adult, donor10258	10373-105G4	73.40	3.67	3.67	1.47	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	51.73	7.52	1.88	1.88	2.82	0.94	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	106.89	9.98	3.71	6.84	4.28	0.29	1.71	0.00
parietal lobe, adult, pool1	10034-101E7	52.34	7.93	4.76	4.05	2.73	1.94	1.06	0.44
parietal lobe, fetal, donor1	10072-101I9	180.39	32.97	18.43	17.46	21.34	6.79	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	45.98	9.35	4.11	1.87	5.23	0.75	1.50	0.00
parotid gland, adult	10199-103F1	38.23	3.08	1.85	0.62	0.00	0.62	0.62	0.62
penis, adult	10200-103F2	63.92	6.98	3.22	3.22	2.69	0.54	1.61	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	72.52	9.30	6.32	2.60	2.23	0.37	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.55	4.95	2.62	1.46	1.60	1.02	0.58	0.00
pineal gland - adult, donor10196	10179-103C8	130.30	17.42	1.29	4.52	5.81	1.29	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	151.01	16.58	1.18	9.48	5.92	1.18	3.55	0.59
pineal gland, adult, donor10258	10377-105G8	73.37	11.29	3.76	3.76	6.27	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	122.43	6.07	2.02	3.04	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	180.33	11.47	3.13	4.17	2.08	2.08	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	68.95	5.11	4.26	5.11	2.55	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	53.11	3.66	1.18	1.29	2.58	0.22	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	37.48	14.96	1.85	1.46	0.26	0.00	0.93	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	54.01	2.18	2.02	1.09	0.00	0.00	0.47	0.31
pons, adult, pool1	10033-101E6	36.75	5.51	1.81	1.98	1.89	1.29	0.77	0.34
postcentral gyrus, adult, pool1	10032-101E5	51.26	5.40	4.79	2.53	3.23	1.31	1.48	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	121.30	48.10	12.55	4.18	8.37	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	5.51	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	26.66	4.95	1.31	1.60	0.58	0.73	0.58	0.00
prostate cancer cell line:PC-3	10439-106E7	54.63	7.99	1.45	1.63	1.82	0.73	0.18	0.00
prostate, adult, pool1	10022-101D4	63.85	5.89	2.18	2.72	2.18	0.82	0.91	0.54
putamen, adult, donor10196	10176-103C5	90.65	10.39	8.73	4.96	2.83	0.94	1.65	0.24
putamen, adult, donor10252	10152-102I8	29.41	9.80	1.96	0.00	0.00	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	9.84	2.19	1.09	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	44.22	8.21	5.56	2.17	1.93	0.48	0.72	0.00
putamen, newborn, donor10223	10365-105F5	48.73	9.00	4.50	1.50	6.00	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	65.46	13.09	4.36	2.91	1.16	1.45	0.29	0.87
rectum, fetal, donor1	10067-101I4	55.64	12.52	8.35	5.56	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.98	2.97	3.39	0.64	0.85	0.85	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.27	0.83	0.83	0.00	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	87.37	9.14	1.79	2.98	2.88	0.30	0.70	1.29
retinoblastoma cell line:Y79	10475-106I7	56.38	24.16	0.78	7.79	3.38	0.00	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.37	13.77	3.93	4.92	4.06	0.37	0.49	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	95.33	42.46	7.59	12.09	9.28	1.12	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.03	3.79	1.52	0.00	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	42.89	3.24	4.53	1.94	0.81	0.65	0.16	0.65
salivary acinar cells, donor2	11772-123I8	43.37	3.99	4.13	1.65	2.89	0.83	0.28	0.69
salivary acinar cells, donor3	11773-123I9	123.14	8.61	7.28	1.99	1.32	1.32	0.66	0.00
salivary gland, adult, pool1	10093-102C3	40.04	1.72	2.86	1.14	0.00	0.00	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	21.42	2.11	0.76	0.59	0.93	0.59	0.00	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	20.45	0.59	0.82	0.35	0.94	0.24	0.12	0.00
seminal vesicle, adult	10201-103F3	86.24	4.23	3.70	3.17	3.17	2.12	0.00	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.35	2.92	2.19	0.24	0.00	0.24	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	18.37	2.01	1.01	0.00	0.00	0.00	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	28.10	2.01	1.00	0.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	56.68	10.75	4.16	2.55	0.81	1.48	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	41.78	4.75	2.43	1.44	1.99	0.77	0.44	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.55	4.90	5.29	0.65	0.90	0.90	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	0.71	0.71	0.71	0.71	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	35.62	5.40	1.08	0.84	2.04	0.36	0.36	0.36
skeletal muscle, fetal, donor1	10066-101I3	61.31	6.03	3.02	2.01	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	71.96	3.16	0.00	3.16	3.79	0.00	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	69.04	6.67	4.34	3.67	2.33	1.33	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	138.38	24.27	5.04	6.30	5.04	1.26	0.95	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	173.09	29.68	8.67	8.29	8.48	3.47	1.93	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	70.05	9.89	4.12	3.13	3.79	1.32	1.15	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	119.35	24.93	1.29	4.34	1.61	0.16	0.64	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	83.90	20.70	6.54	11.55	10.46	0.87	0.87	0.65
small intestine, adult, pool1	10024-101D6	55.18	5.61	3.46	3.46	3.34	0.96	0.72	2.03
small intestine, fetal, donor1	10064-101I1	68.06	5.90	3.93	1.97	0.74	0.49	1.23	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	51.80	7.18	5.13	3.08	3.08	1.54	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	66.16	5.17	2.07	1.03	1.81	0.78	1.03	1.03
somatostatinoma cell line:QGP-1	10781-110G7	49.05	7.50	6.16	3.48	2.41	0.80	1.61	0.00
spinal cord - adult, donor10196	10181-103D1	62.63	8.26	1.38	3.90	3.44	1.15	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	85.56	10.25	0.79	5.91	3.15	0.39	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	38.74	5.53	1.38	1.38	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	70.74	9.15	4.27	4.27	3.05	1.83	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	45.46	3.67	0.92	1.38	1.84	0.92	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	29.27	4.33	1.79	1.05	1.19	0.30	0.15	0.00
spleen, adult, pool1	10025-101D7	53.97	9.36	2.42	3.41	2.75	0.55	1.21	1.32
spleen, fetal, pool1	10044-101F8	55.30	10.17	2.38	2.86	2.07	0.79	0.48	1.67
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.92	16.15	2.38	2.38	0.72	0.52	0.83	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	41.20	6.84	3.42	2.66	1.52	0.76	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	58.36	10.48	2.10	4.54	5.24	1.05	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.40	17.59	7.04	4.30	0.78	1.56	3.13	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	20.82	11.82	3.49	2.14	1.80	0.34	1.69	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	12.71	10.59	5.51	3.81	3.39	1.27	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.85	8.04	2.54	1.27	0.85	0.85	0.85	0.00
stomach, fetal, donor1	10062-101H8	89.71	10.68	4.27	9.61	4.27	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	59.25	5.70	1.71	1.71	1.71	0.57	0.00	2.28
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	97.83	9.55	1.04	2.08	1.45	0.62	1.45	0.00
substantia nigra, adult, donor10258	10371-105G2	43.97	5.17	2.59	0.52	0.52	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	31.09	9.19	1.41	2.12	2.12	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	53.65	15.36	10.32	7.11	4.36	2.06	1.15	0.00
temporal lobe, adult, pool1	10031-101E4	45.52	6.53	5.00	3.65	3.48	1.95	1.02	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	168.10	23.50	22.79	14.96	14.25	2.85	2.85	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	116.48	23.30	28.57	8.35	7.91	1.76	1.76	1.32
tenocyte, donor1	11763-123H8	24.09	1.40	1.75	0.35	0.35	0.00	0.35	0.00
tenocyte, donor2	11765-123I1	23.65	0.38	1.14	0.38	0.38	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	17.05	0.74	0.37	0.37	0.00	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	39.60	23.45	2.72	4.25	1.87	1.53	1.19	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	51.18	23.74	4.93	6.78	1.70	0.77	0.62	0.62
teratocarcinoma cell line:PA-1	10807-111A6	24.18	15.34	1.39	2.94	1.86	0.46	1.55	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.69	17.01	7.11	4.19	2.29	1.14	0.51	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	90.01	20.04	5.29	7.94	4.16	1.13	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	42.75	15.38	6.54	3.05	2.18	2.29	1.09	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	35.50	20.19	2.61	5.21	2.28	0.33	0.98	0.65
testis, adult, pool1	10026-101D8	90.52	7.84	2.47	6.66	10.63	0.97	0.54	1.93
testis, adult, pool2	10096-102C6	130.81	21.20	4.51	8.57	5.86	1.35	0.90	0.00
thalamus - adult, donor10196	10168-103B6	57.41	9.94	1.10	5.52	3.31	2.21	1.10	1.10
thalamus, adult, donor10252	10154-103A1	90.18	12.50	3.44	5.16	5.47	1.25	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	13.86	6.16	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.12	4.12	1.98	1.32	2.31	0.49	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	28.19	5.75	1.73	3.45	4.03	1.73	0.00	0.58
throat, adult	10209-103G2	44.94	4.24	2.50	2.00	1.25	0.25	0.25	0.50
throat, fetal, donor1	10061-101H7	60.33	12.80	3.66	3.35	0.91	2.13	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	30.01	15.10	12.12	2.78	2.38	3.78	1.19	0.40
thymus, adult, pool1	10027-101D9	108.86	28.63	6.06	9.15	8.05	1.79	2.98	3.08
thymus, fetal, pool1	10043-101F7	101.31	22.55	4.68	7.38	3.74	0.83	1.66	1.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.89	7.31	3.99	2.13	0.66	0.80	0.93	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	52.80	6.43	2.37	0.98	1.40	1.12	0.84	0.28
thyroid, adult, pool1	10028-101E1	66.44	3.83	1.68	1.68	1.77	0.19	0.56	0.56
thyroid, fetal, donor1	10060-101H6	67.76	8.96	2.64	3.16	3.69	1.05	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	39.54	3.72	3.26	0.47	1.40	0.70	0.47	0.00
tongue, fetal, donor1	10059-101H5	49.66	8.28	3.94	1.58	2.36	1.18	0.79	0.79
tonsil, adult, pool1	10047-101G2	63.51	12.12	3.91	3.51	1.60	1.60	1.50	1.30
trachea, adult, pool1	10029-101E2	44.50	4.66	2.04	1.55	1.80	0.65	0.57	0.25
trachea, fetal, donor1	10058-101H4	52.32	10.39	1.54	1.92	2.31	0.77	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.84	4.61	1.77	0.35	0.71	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	52.89	9.52	5.17	3.75	3.95	1.52	0.81	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	59.07	5.33	2.04	2.35	2.35	0.94	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	85.61	7.61	11.42	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	36.74	6.18	4.83	2.54	1.69	0.93	0.25	0.68
umbilical cord, fetal, donor1	10057-101H3	43.82	6.26	2.09	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	78.32	9.73	5.12	2.22	2.56	0.68	1.37	0.00
uterus, fetal, donor1	10055-101H1	59.90	6.14	4.10	2.56	1.54	1.54	3.58	0.51
vagina, adult	10204-103F6	76.90	7.75	3.23	0.00	1.94	1.29	1.29	0.00
vein, adult	10191-103E2	53.48	12.49	4.38	2.19	2.63	1.32	1.97	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.16	13.35	0.27	0.80	0.00	0.00	0.53	0.00